<div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Medication used as chemotherapy and to suppress the immune system</div>
<style data-mw-deduplicate="TemplateStyles:r1066479718">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}</style><table class="infobox" style="border-spacing:2px;"><caption class="infobox-title"><span title="International nonproprietary name (INN): Cyclophosphamide">Cyclophosphamide</span></caption><tbody><tr><td colspan="2" class="infobox-image"><a href="/wiki/File:Cyclophosphamide.svg" class="image"><img alt="Cyclophosphamide.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Cyclophosphamide.svg/125px-Cyclophosphamide.svg.png" decoding="async" width="125" height="160" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Cyclophosphamide.svg/188px-Cyclophosphamide.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5c/Cyclophosphamide.svg/250px-Cyclophosphamide.svg.png 2x" data-file-width="512" data-file-height="657" /></a></td></tr><tr><td colspan="2" class="infobox-image"><a href="/wiki/File:R-cyclophosphamide-from-xtal-1996-3D-balls.png" class="image"><img alt="R-cyclophosphamide-from-xtal-1996-3D-balls.png" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/R-cyclophosphamide-from-xtal-1996-3D-balls.png/125px-R-cyclophosphamide-from-xtal-1996-3D-balls.png" decoding="async" width="125" height="181" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/R-cyclophosphamide-from-xtal-1996-3D-balls.png/188px-R-cyclophosphamide-from-xtal-1996-3D-balls.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b6/R-cyclophosphamide-from-xtal-1996-3D-balls.png/250px-R-cyclophosphamide-from-xtal-1996-3D-balls.png 2x" data-file-width="1378" data-file-height="2000" /></a></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Clinical data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">Pronunciation</th><td class="infobox-data"><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt"><a href="/wiki/Help:IPA/English" title="Help:IPA/English">/<span style="border-bottom:1px dotted"><span title="/ˌ/: secondary stress follows">ˌ</span><span title="&#39;s&#39; in &#39;sigh&#39;">s</span><span title="/aɪ/: &#39;i&#39; in &#39;tide&#39;">aɪ</span><span title="&#39;k&#39; in &#39;kind&#39;">k</span><span title="&#39;l&#39; in &#39;lie&#39;">l</span><span title="/oʊ/: &#39;o&#39; in &#39;code&#39;">oʊ</span><span title="/ˈ/: primary stress follows">ˈ</span><span title="&#39;f&#39; in &#39;find&#39;">f</span><span title="/ɒ/: &#39;o&#39; in &#39;body&#39;">ɒ</span><span title="&#39;s&#39; in &#39;sigh&#39;">s</span><span title="&#39;f&#39; in &#39;find&#39;">f</span><span title="/ə/: &#39;a&#39; in &#39;about&#39;">ə</span><span title="/ˌ/: secondary stress follows">ˌ</span><span title="&#39;m&#39; in &#39;my&#39;">m</span><span title="/aɪ/: &#39;i&#39; in &#39;tide&#39;">aɪ</span><span title="&#39;d&#39; in &#39;dye&#39;">d</span></span>,<span class="wrap"> </span>-<span style="border-bottom:1px dotted"><span title="&#39;l&#39; in &#39;lie&#39;">l</span><span title="/ə/: &#39;a&#39; in &#39;about&#39;">ə</span></span>-/</a></span></span><sup id="cite_ref-1" class="reference"><a href="#cite_note-1">&#91;1&#93;</a></sup><sup id="cite_ref-2" class="reference"><a href="#cite_note-2">&#91;2&#93;</a></sup>&#x20;</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Drug_nomenclature#Trade_names" title="Drug nomenclature">Trade names</a></th><td class="infobox-data">Lyophilized Cytoxan, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cycloblastin</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">AHFS</a>/<a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a></th><td class="infobox-data"><span title="www.drugs.com"><a rel="nofollow" class="external text" href="https://www.drugs.com/monograph/cyclophosphamide.html">Monograph</a></span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th><td class="infobox-data"><span title="medlineplus.gov"><a rel="nofollow" class="external text" href="https://medlineplus.gov/druginfo/meds/a682080.html">a682080</a></span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy<br />category</a></th><td class="infobox-data"><div class="plainlist">
<ul><li><small><abbr class="country-name" title="Australia">AU</abbr>:</small>&#x20;D</li>
<li class="mw-empty-elt"></li></ul>
</div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes of<br />administration</a></th><td class="infobox-data"><a href="/wiki/Oral_administration" title="Oral administration">By mouth</a>, <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">by injection into a vein</a></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th><td class="infobox-data"><div class="plainlist"><ul><li><a href="/wiki/ATC_code_L01" title="ATC code L01">L01AA01</a>&#x20;(<span title="www.whocc.no"><a rel="nofollow" class="external text" href="https://www.whocc.no/atc_ddd_index/?code=L01AA01">WHO</a></span>)&#x20;</li></ul></div></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Legal status</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th><td class="infobox-data"><div class="plainlist">
<ul><li><small><abbr class="country-name" title="Australia">AU</abbr>:</small>&#x20;<a href="/wiki/Standard_for_the_Uniform_Scheduling_of_Medicines_and_Poisons#Schedule_4" title="Standard for the Uniform Scheduling of Medicines and Poisons">S4</a> (Prescription only)&#x20;</li>
<li><small><abbr class="country-name" title="Canada">CA</abbr></small>:&#x20;<a href="/wiki/Prescription_drug" title="Prescription drug"> ℞-only</a>&#x20;</li>
<li><small><abbr class="country-name" title="United Kingdom">UK</abbr>:</small>&#x20;<a href="/wiki/Prescription_drug" title="Prescription drug">POM</a> (Prescription only)&#x20;</li>
<li><small><abbr class="country-name" title="United States">US</abbr>:</small>&#x20;<a href="/wiki/Prescription_drug" title="Prescription drug">℞-only</a>&#x20;</li>
<li>In&#160;general: ℞&#160;(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd"><a href="/wiki/Pharmacokinetics" title="Pharmacokinetics">Pharmacokinetic</a> data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></th><td class="infobox-data">&gt;75% (by mouth)</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Protein binding</a></th><td class="infobox-data">&gt;60%</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></th><td class="infobox-data"><a href="/wiki/Liver" title="Liver">Liver</a></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Biological_half-life" title="Biological half-life">Elimination <span class="nowrap">half-life</span></a></th><td class="infobox-data">3–12 hours</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></th><td class="infobox-data"><a href="/wiki/Kidney" title="Kidney">Kidney</a></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Identifiers</th></tr><tr><td colspan="2" class="infobox-full-data"><div class="mw-collapsible mw-collapsed" style="text-align: center; font-size: 95%;">
<div style="line-height: 1.6em; font-weight: bold; font-size: 100%; text-align: left;"><div><a href="/wiki/IUPAC_nomenclature_of_chemistry" title="IUPAC nomenclature of chemistry">IUPAC name</a></div></div>
<ul class="mw-collapsible-content" style="font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit; text-align: left; list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em;"><li style="line-height: inherit; margin: 0"><div style="font-size: 97%;">(<i>RS</i>)-<i>N</i>,<i>N</i>-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide</div></li></ul>
</div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/CAS_Registry_Number" title="CAS Registry Number">CAS Number</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="commonchemistry.cas.org"><a rel="nofollow" class="external text" href="https://commonchemistry.cas.org/detail?cas_rn=50-18-0">50-18-0</a></span><sup>&#160;<img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/PubChem#CID" title="PubChem">PubChem</a> <span style="font-weight:normal"><abbr title="Compound ID">CID</abbr></span></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="pubchem.ncbi.nlm.nih.gov"><a rel="nofollow" class="external text" href="https://pubchem.ncbi.nlm.nih.gov/compound/2907">2907</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.drugbank.ca"><a rel="nofollow" class="external text" href="https://www.drugbank.ca/drugs/DB00531">DB00531</a></span><sup>&#160;<img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.chemspider.com"><a rel="nofollow" class="external text" href="https://www.chemspider.com/Chemical-Structure.2804.html">2804</a></span><sup>&#160;<img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Unique_Ingredient_Identifier" title="Unique Ingredient Identifier">UNII</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="fdasis.nlm.nih.gov"><a rel="nofollow" class="external text" href="https://fdasis.nlm.nih.gov/srs/unii/6UXW23996M">6UXW23996M</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/KEGG" title="KEGG">KEGG</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.kegg.jp"><a rel="nofollow" class="external text" href="https://www.kegg.jp/entry/D07760">D07760</a></span><sup>&#160;<img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ChEBI" title="ChEBI">ChEBI</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.ebi.ac.uk"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:4027">CHEBI:4027</a></span><sup>&#160;<img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ChEMBL" title="ChEMBL">ChEMBL</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.ebi.ac.uk"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL88">ChEMBL88</a></span><sup>&#160;<img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/CompTox_Chemicals_Dashboard" title="CompTox Chemicals Dashboard">CompTox Dashboard</a> <span style="font-weight:normal">(<abbr title="U.S. Environmental Protection Agency">EPA</abbr>)</span></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="comptox.epa.gov"><a rel="nofollow" class="external text" href="https://comptox.epa.gov/dashboard/chemical/details/DTXSID5020364">DTXSID5020364</a> <a href="https://www.wikidata.org/wiki/Q408524#P3117" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ECHA_InfoCard" class="mw-redirect" title="ECHA InfoCard"><span title="echa.europa.eu">ECHA InfoCard</span></a></th><td class="infobox-data"><a rel="nofollow" class="external text" href="https://echa.europa.eu/substance-information/-/substanceinfo/100.000.015">100.000.015</a> <a href="https://www.wikidata.org/wiki/Q408524#P2566" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></th><td class="infobox-data"><span title="Carbon">C</span><sub>7</sub><span title="Hydrogen">H</span><sub>15</sub><span title="Chlorine">Cl</span><sub>2</sub><span title="Nitrogen">N</span><sub>2</sub><span title="Oxygen">O</span><sub>2</sub><span title="Phosphorus">P</span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Molar_mass" title="Molar mass">Molar mass</a></th><td class="infobox-data"><span class="nowrap"><span data-sort-value="7002261079999999999♠"></span>261.08</span>&#160;g·mol<sup>−1</sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">3D model (<a href="/wiki/JSmol" class="mw-redirect" title="JSmol">JSmol</a>)</th><td class="infobox-data"><div class="plainlist"><ul><li><span title="chemapps.stolaf.edu (3D interactive model)"><a rel="nofollow" class="external text" href="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DP1%28OCCCN1%29N%28CCCl%29CCCl">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Melting_point" title="Melting point">Melting point</a></th><td class="infobox-data">2&#160;°C (36&#160;°F)</td></tr><tr><td colspan="2" class="infobox-full-data"><div class="mw-collapsible mw-collapsed" style="text-align: center; font-size: 95%;">
<div style="line-height: 1.6em; font-weight: bold; font-size: 100%; text-align: left;"><div><a href="/wiki/Simplified_molecular-input_line-entry_system" title="Simplified molecular-input line-entry system">SMILES</a></div></div>
<ul class="mw-collapsible-content" style="font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit; text-align: left; list-style: none none; margin-left: 0; word-break:break-all;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">O=P1(OCCCN1)N(CCCl)CCCl</div></li></ul>
</div></td></tr><tr><td colspan="2" class="infobox-full-data"><div class="mw-collapsible mw-collapsed" style="text-align: center; font-size: 95%;">
<div style="line-height: 1.6em; font-weight: bold; font-size: 100%; text-align: left;"><div><a href="/wiki/International_Chemical_Identifier" title="International Chemical Identifier">InChI</a></div></div>
<ul class="mw-collapsible-content" style="font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit; text-align: left; list-style: none none; margin-left: 0; word-break:break-all;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)<sup>&#160;<img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">Key:CMSMOCZEIVJLDB-UHFFFAOYSA-N<sup>&#160;<img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" class="infobox-below"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold">&#160;&#160;<span class="reflink plainlinks nourlexpansion"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=459435450&amp;page2=Cyclophosphamide">(verify)</a></span></span></td></tr></tbody></table>
<p><b>Cyclophosphamide</b> (<b>CP</b>), also known as <b>cytophosphane</b> among other names,<sup id="cite_ref-3" class="reference"><a href="#cite_note-3">&#91;3&#93;</a></sup> is a medication used as <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> and to <a href="/wiki/Immunosuppressant" class="mw-redirect" title="Immunosuppressant">suppress the immune system</a>.<sup id="cite_ref-AHFS2016_4-0" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup> As chemotherapy it is used to treat <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a>, <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a>, <a href="/wiki/Leukemia" title="Leukemia">leukemia</a>, <a href="/wiki/Ovarian_cancer" title="Ovarian cancer">ovarian cancer</a>, <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>, <a href="/wiki/Small_cell_lung_cancer" class="mw-redirect" title="Small cell lung cancer">small cell lung cancer</a>, <a href="/wiki/Neuroblastoma" title="Neuroblastoma">neuroblastoma</a>, and <a href="/wiki/Sarcoma" title="Sarcoma">sarcoma</a>.<sup id="cite_ref-AHFS2016_4-1" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup> As an immune suppressor it is used in <a href="/wiki/Nephrotic_syndrome" title="Nephrotic syndrome">nephrotic syndrome</a>, <a href="/wiki/Granulomatosis_with_polyangiitis" title="Granulomatosis with polyangiitis">granulomatosis with polyangiitis</a>, and following <a href="/wiki/Organ_transplant" class="mw-redirect" title="Organ transplant">organ transplant</a>, among other conditions.<sup id="cite_ref-AHFS2016_4-2" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup><sup id="cite_ref-Pagnoux_5-0" class="reference"><a href="#cite_note-Pagnoux-5">&#91;5&#93;</a></sup> It is taken by mouth or <a href="/wiki/Intravenous" class="mw-redirect" title="Intravenous">injection into a vein</a>.<sup id="cite_ref-AHFS2016_4-3" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup> 
</p><p>Most people develop side effects.<sup id="cite_ref-AHFS2016_4-4" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup> Common side effects include <a href="/wiki/Leukopenia" title="Leukopenia">low white blood cell counts</a>, loss of appetite, vomiting, <a href="/wiki/Hair_loss" title="Hair loss">hair loss</a>, and <a href="/wiki/Hemorrhagic_cystitis" title="Hemorrhagic cystitis">bleeding from the bladder</a>.<sup id="cite_ref-AHFS2016_4-5" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup> Other severe side effects include an increased future risk of cancer, <a href="/wiki/Infertility" title="Infertility">infertility</a>, <a href="/wiki/Allergic_reactions" class="mw-redirect" title="Allergic reactions">allergic reactions</a>, and <a href="/wiki/Pulmonary_fibrosis" title="Pulmonary fibrosis">pulmonary fibrosis</a>.<sup id="cite_ref-AHFS2016_4-6" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup> Cyclophosphamide is in the <a href="/wiki/Alkylating_antineoplastic_agent" title="Alkylating antineoplastic agent">alkylating agent</a> and <a href="/wiki/Nitrogen_mustard" title="Nitrogen mustard">nitrogen mustard</a> family of medications.<sup id="cite_ref-AHFS2016_4-7" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup> It is believed to work by interfering with the duplication of <a href="/wiki/DNA" title="DNA">DNA</a> and the creation of <a href="/wiki/RNA" title="RNA">RNA</a>.<sup id="cite_ref-AHFS2016_4-8" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup>
</p><p>Cyclophosphamide was approved for medical use in the United States in 1959.<sup id="cite_ref-AHFS2016_4-9" class="reference"><a href="#cite_note-AHFS2016-4">&#91;4&#93;</a></sup> It is on the <a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">World Health Organization's List of Essential Medicines</a>.<sup id="cite_ref-WHO21st_6-0" class="reference"><a href="#cite_note-WHO21st-6">&#91;6&#93;</a></sup>
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Medical_uses"><span class="tocnumber">1</span> <span class="toctext">Medical uses</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Cancer"><span class="tocnumber">1.1</span> <span class="toctext">Cancer</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Autoimmune_diseases"><span class="tocnumber">1.2</span> <span class="toctext">Autoimmune diseases</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#AL_amyloidosis"><span class="tocnumber">1.3</span> <span class="toctext">AL amyloidosis</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Graft-versus-host_disease"><span class="tocnumber">1.4</span> <span class="toctext">Graft-versus-host disease</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-6"><a href="#Contraindications"><span class="tocnumber">2</span> <span class="toctext">Contraindications</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Side_effects"><span class="tocnumber">3</span> <span class="toctext">Side effects</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Bladder_bleeding"><span class="tocnumber">3.1</span> <span class="toctext">Bladder bleeding</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Infection"><span class="tocnumber">3.2</span> <span class="toctext">Infection</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Infertility"><span class="tocnumber">3.3</span> <span class="toctext">Infertility</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Cancer_2"><span class="tocnumber">3.4</span> <span class="toctext">Cancer</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Pharmacology"><span class="tocnumber">4</span> <span class="toctext">Pharmacology</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Mechanism_of_action"><span class="tocnumber">5</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#History"><span class="tocnumber">6</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Society_and_culture"><span class="tocnumber">7</span> <span class="toctext">Society and culture</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#Research"><span class="tocnumber">8</span> <span class="toctext">Research</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-18"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul>
</div>

<h2><span class="mw-headline" id="Medical_uses">Medical uses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=1" title="Edit section: Medical uses">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Cyclophosphamide is used to treat cancers and <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a>. It is used to quickly control the disease. Due to its toxicity, it is replaced as soon as possible by less toxic drugs. Regular and frequent laboratory evaluations are required to monitor kidney function, avoid drug-induced bladder complications and screen for <a href="/wiki/Bone_marrow_suppression" title="Bone marrow suppression">bone marrow toxicity</a>.
</p>
<h3><span class="mw-headline" id="Cancer">Cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=2" title="Edit section: Cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tleft"><div class="thumbinner" style="width:152px;"><a href="/wiki/File:Cyclophosphamide_iv.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d5/Cyclophosphamide_iv.jpg/150px-Cyclophosphamide_iv.jpg" decoding="async" width="150" height="225" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d5/Cyclophosphamide_iv.jpg/225px-Cyclophosphamide_iv.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d5/Cyclophosphamide_iv.jpg/300px-Cyclophosphamide_iv.jpg 2x" data-file-width="1800" data-file-height="2700" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Cyclophosphamide_iv.jpg" class="internal" title="Enlarge"></a></div>Cyclophosphamide IV drip</div></div></div>
<p>The main use of cyclophosphamide is with other <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> agents in the treatment of <a href="/wiki/Lymphoma" title="Lymphoma">lymphomas</a>, some forms of <a href="/wiki/Brain_cancer" class="mw-redirect" title="Brain cancer">brain cancer</a>, <a href="/wiki/Neuroblastoma" title="Neuroblastoma">neuroblastoma</a>, <a href="/wiki/Leukemia" title="Leukemia">leukemia</a> and some solid tumors.<sup id="cite_ref-MD_7-0" class="reference"><a href="#cite_note-MD-7">&#91;7&#93;</a></sup>
</p><p>Oncovet C (Chemovet S.A.), is the first-based drug approved in Latin America for veterinary use for canine and feline cancer (carcinomas of anal sacs, bladder carcinomas, urethral carcinomas, hemangiosarcomas, lymphomas, mast cell tumor, osteosarcomas, soft tissue sarcoma), feline cancers (mammary carcinomas, hemangiosarcomas, lymphomas, plasmacytomas, chronic lymphocytic leukemia, leukemia acute myelogenous, mast cell tumor). It can be administered in different treatment schemes, such as induction therapy, adjuvant, neoadjuvant, maintenance and metronomic chemotherapy.
</p>
<h3><span class="mw-headline" id="Autoimmune_diseases">Autoimmune diseases</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=3" title="Edit section: Autoimmune diseases">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Cyclophosphamide <a href="/wiki/Immunosuppression" title="Immunosuppression">decreases the immune system's response</a>, and although concerns about toxicity restrict its use to patients with severe disease, it remains an important treatment for life-threatening <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a> where <a href="/wiki/Disease-modifying_antirheumatic_drug" title="Disease-modifying antirheumatic drug">disease-modifying antirheumatic drugs</a> (DMARDs) have been ineffective.   For example, <a href="/wiki/Systemic_lupus_erythematosus" class="mw-redirect" title="Systemic lupus erythematosus">systemic lupus erythematosus</a> with severe <a href="/wiki/Lupus_nephritis" title="Lupus nephritis">lupus nephritis</a> may respond to pulsed cyclophosphamide. Cyclophosphamide is also used to treat <a href="/wiki/Minimal_change_disease" title="Minimal change disease">minimal change disease</a>,<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">&#91;8&#93;</a></sup> severe <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, <a href="/wiki/Granulomatosis_with_polyangiitis" title="Granulomatosis with polyangiitis">granulomatosis with polyangiitis</a>,<sup id="cite_ref-Pagnoux_5-1" class="reference"><a href="#cite_note-Pagnoux-5">&#91;5&#93;</a></sup> <a href="/wiki/Goodpasture_syndrome" title="Goodpasture syndrome">Goodpasture syndrome</a><sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup> and <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10">&#91;10&#93;</a></sup>
</p><p>Because of its potential side effects such as <a href="/wiki/Amenorrhea" title="Amenorrhea">amenorrhea</a> or <a href="/wiki/Ovarian_failure" class="mw-redirect" title="Ovarian failure">ovarian failure</a>, cyclophosphamide is used for early phases of treatment and later substituted by other medications, such as <a href="/wiki/Mycophenolic_acid" title="Mycophenolic acid">mycophenolic acid</a> or ACA.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11">&#91;11&#93;</a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12">&#91;12&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="AL_amyloidosis">AL amyloidosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=4" title="Edit section: AL amyloidosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Cyclophosphamide, used in combination with <a href="/wiki/Thalidomide" title="Thalidomide">thalidomide</a> or <a href="/wiki/Lenalidomide" title="Lenalidomide">lenalidomide</a> and <a href="/wiki/Dexamethasone" title="Dexamethasone">dexamethasone</a> has documented efficacy as an <a href="/wiki/Off-label_use" title="Off-label use">off-label treatment</a> of <a href="/wiki/AL_amyloidosis" title="AL amyloidosis">AL amyloidosis</a>. It appears to be an alternative to the more traditional treatment with <a href="/wiki/Melphalan" title="Melphalan">melphalan</a> in people who are ill-suited for autologous stem cell transplant.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup><sup id="cite_ref-MD_7-1" class="reference"><a href="#cite_note-MD-7">&#91;7&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Graft-versus-host_disease">Graft-versus-host disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=5" title="Edit section: Graft-versus-host disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Graft-versus-host_disease" title="Graft-versus-host disease">Graft-versus-host disease</a> (GVHD) is a major barrier for <a href="/wiki/Allogeneic_stem_cell_transplant" class="mw-redirect" title="Allogeneic stem cell transplant">allogeneic stem cell transplant</a> because of the immune reactions of donor <a href="/wiki/T_cell" title="T cell">T cell</a> against the person receiving them. GVHD can often be avoided by <a href="/wiki/T-cell_depletion" title="T-cell depletion">T-cell depletion</a> of the graft.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup> The use of a high dose cyclophosphamide post-transplant in a half matched or haploidentical donor <a href="/wiki/Hematopoietic_stem_cell_transplantation" title="Hematopoietic stem cell transplantation">hematopoietic stem cell transplantation</a> reduces GVHD, even after using a reduced <a href="/wiki/Conditioning_regimen" class="mw-redirect" title="Conditioning regimen">conditioning regimen</a>.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Contraindications">Contraindications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=6" title="Edit section: Contraindications">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Like other alkylating agents, cyclophosphamide is <a href="/wiki/Teratogenic" class="mw-redirect" title="Teratogenic">teratogenic</a> and contraindicated in pregnant women (<a href="/wiki/Pregnancy_category" title="Pregnancy category">pregnancy category</a> D) except for life-threatening circumstances in the mother. Additional relative contraindications to the use of cyclophosphamide include <a href="/wiki/Lactation" title="Lactation">lactation</a>, active infection, <a href="/wiki/Neutropenia" title="Neutropenia">neutropenia</a> or bladder toxicity.<sup id="cite_ref-MD_7-2" class="reference"><a href="#cite_note-MD-7">&#91;7&#93;</a></sup>
</p><p>Cyclophosphamide is a <a href="/wiki/Pregnancy_category" title="Pregnancy category">pregnancy category</a> D drug and causes birth defects. First trimester exposure to cyclophosphamide for the treatment of <a href="/wiki/Cancer" title="Cancer">cancer</a> or <a href="/wiki/Systemic_lupus_erythematosus" class="mw-redirect" title="Systemic lupus erythematosus">lupus</a> displays a pattern of anomalies labeled "cyclophosphamide embryopathy", including <a href="/wiki/Intrauterine_growth_restriction" title="Intrauterine growth restriction">growth restriction</a>, ear and facial abnormalities, absence of digits and hypoplastic limbs.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17">&#91;17&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Side_effects">Side effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=7" title="Edit section: Side effects">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">Adverse drug reactions</a> from cyclophosphamide are related to the cumulative medication dose and include <a href="/wiki/Chemotherapy-induced_nausea_and_vomiting" title="Chemotherapy-induced nausea and vomiting">chemotherapy-induced nausea and vomiting</a>,<sup id="cite_ref-18" class="reference"><a href="#cite_note-18">&#91;18&#93;</a></sup> <a href="/wiki/Bone_marrow_suppression" title="Bone marrow suppression">bone marrow suppression</a>,<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup> <a href="/wiki/Abdominal_pain" title="Abdominal pain">stomach ache</a>, <a href="/wiki/Hemorrhagic_cystitis" title="Hemorrhagic cystitis">hemorrhagic cystitis</a>, <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, darkening of the skin/nails, <a href="/wiki/Alopecia" class="mw-redirect" title="Alopecia">alopecia</a> (hair loss) or thinning of hair, changes in color and texture of the hair, <a href="/wiki/Lethargy" title="Lethargy">lethargy</a>, and profound gonadotoxicity. Other side effects may include easy bruising/bleeding, joint pain, mouth sores, slow-healing existing wounds, unusual decrease in the amount of urine or unusual tiredness or weakness.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (May 2014)">citation needed</span></a></i>&#93;</sup> Potential side effects also include leukopenia, infection, bladder toxicity, and cancer.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20">&#91;20&#93;</a></sup>
</p><p>Pulmonary injury appears rare,<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup> but can present with two clinical patterns: an early, acute <a href="/wiki/Pneumonitis" title="Pneumonitis">pneumonitis</a> and a chronic, progressive <a href="/wiki/Pulmonary_fibrosis" title="Pulmonary fibrosis">fibrosis</a>.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup> <a href="/wiki/Cardiotoxicity" title="Cardiotoxicity">Cardiotoxicity</a> is a major problem with people treated with higher dose regimens.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup>
</p><p>High-dose intravenous cyclophosphamide can cause the <a href="/wiki/Syndrome_of_inappropriate_antidiuretic_hormone_secretion" title="Syndrome of inappropriate antidiuretic hormone secretion">syndrome of inappropriate antidiuretic hormone secretion</a> (SIADH) and a potentially fatal <a href="/wiki/Hyponatremia" title="Hyponatremia">hyponatremia</a> when compounded by intravenous fluids administered to prevent drug-induced cystitis.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup> While SIADH has been described primarily with higher doses of cyclophosphamide, it can also occur with the lower doses used in the management of inflammatory disorders.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Bladder_bleeding">Bladder bleeding</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=8" title="Edit section: Bladder bleeding">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Acrolein" title="Acrolein">Acrolein</a> is toxic to the <a href="/wiki/Urinary_bladder" title="Urinary bladder">bladder</a> <a href="/wiki/Epithelium" title="Epithelium">epithelium</a> and can lead to <a href="/wiki/Hemorrhagic_cystitis" title="Hemorrhagic cystitis">hemorrhagic cystitis</a>, which is associated with microscopic or gross <a href="/wiki/Hematuria" title="Hematuria">hematuria</a> and occasionally <a href="/wiki/Dysuria" title="Dysuria">dysuria</a>.<sup id="cite_ref-pmid19786984_26-0" class="reference"><a href="#cite_note-pmid19786984-26">&#91;26&#93;</a></sup> Risks of hemorrhagic cystitis can be minimized with adequate fluid intake, avoidance of nighttime dosage and <a href="/wiki/Mesna" title="Mesna">mesna</a> (sodium 2-mercaptoethane sulfonate), a sulfhydryl donor which binds and detoxifies acrolein.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup> Intermittent dosing of cyclophosphamide decreases cumulative drug dose, reduces bladder exposure to acrolein and has equal efficacy to daily treatment in the management of <a href="/wiki/Lupus_nephritis" title="Lupus nephritis">lupus nephritis</a>.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Infection">Infection</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=9" title="Edit section: Infection">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Neutropenia" title="Neutropenia">Neutropenia</a> or <a href="/wiki/Lymphopenia" class="mw-redirect" title="Lymphopenia">lymphopenia</a> arising secondary to cyclophosphamide usage can predispose people to a variety of <a href="/wiki/Pathogenic_bacteria" title="Pathogenic bacteria">bacterial</a>, <a href="/wiki/Mycosis" class="mw-redirect" title="Mycosis">fungal</a> and <a href="/wiki/Opportunistic_infection" title="Opportunistic infection">opportunistic infections</a>.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup> No published guidelines cover <a href="/wiki/Pneumocystis_pneumonia" title="Pneumocystis pneumonia">PCP</a> prophylaxis for people with <a href="/wiki/Rheumatism" title="Rheumatism">rheumatological diseases</a> receiving <a href="/wiki/Immunosuppressive_drugs" class="mw-redirect" title="Immunosuppressive drugs">immunosuppressive drugs</a>, but some advocate its use when receiving high-dose medication.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup><sup id="cite_ref-Kronbichler2015_31-0" class="reference"><a href="#cite_note-Kronbichler2015-31">&#91;31&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Infertility">Infertility</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=10" title="Edit section: Infertility">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Cyclophosphamide has been found to significantly increase the risk of <a href="/wiki/Premature_ovarian_failure" class="mw-redirect" title="Premature ovarian failure">premature menopause</a> in females and of <a href="/wiki/Infertility" title="Infertility">infertility</a> in males and females, the likelihood of which increases with cumulative drug dose and increasing patient age. Such infertility is usually temporary, but can be permanent.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32">&#91;32&#93;</a></sup> The use of <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a> in women of reproductive age before administration of intermittently dosed cyclophosphamide may diminish the risks of premature menopause and infertility.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Cancer_2">Cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=11" title="Edit section: Cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Cyclophosphamide is <a href="/wiki/Carcinogen" title="Carcinogen">carcinogenic</a> and may increase the risk of developing <a href="/wiki/Lymphoma" title="Lymphoma">lymphomas</a>, <a href="/wiki/Leukemia" title="Leukemia">leukemia</a>, <a href="/wiki/Skin_cancer" title="Skin cancer">skin cancer</a>, <a href="/wiki/Transitional_cell_carcinoma" title="Transitional cell carcinoma">transitional cell carcinoma</a> of the bladder or other malignancies.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">&#91;34&#93;</a></sup> <a href="/wiki/Myeloproliferative_neoplasms" class="mw-redirect" title="Myeloproliferative neoplasms">Myeloproliferative neoplasms</a>, including <a href="/wiki/Acute_leukemia" title="Acute leukemia">acute leukemia</a>, <a href="/wiki/Non-Hodgkin_lymphoma" title="Non-Hodgkin lymphoma">non-Hodgkin lymphoma</a> and <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a>, occurred in 5 of 119 <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a> patients within the first decade after receiving cyclophosphamide, compared with one case of <a href="/wiki/Chronic_lymphocytic_leukemia" title="Chronic lymphocytic leukemia">chronic lymphocytic leukemia</a> in 119 rheumatoid arthritis patients with no history.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">&#91;35&#93;</a></sup> Secondary <a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">acute myeloid leukemia</a> (therapy-related AML, or "t-AML") is thought to occur either by cyclophosphamide-inducing mutations or selecting for a high-risk myeloid clone.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup>
</p><p>This risk may be dependent on dose and other factors, including the condition, other agents or treatment modalities (including <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiotherapy</a>), treatment length and intensity. For some regimens, it is rare. For instance, CMF-therapy for <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a> (where the cumulative dose is typically less than 20&#160;grams of cyclophosphamide) carries an AML risk of less than 1/2000, with some studies finding no increased risk compared to background. Other treatment regimens involving higher doses may carry risks of 1–2% or higher. Cyclophosphamide-induced AML, when it happens, typically presents some years after treatment, with incidence peaking around 3–9 years. After nine years, the risk falls to background. When AML occurs, it is often preceded by a <a href="/wiki/Myelodysplastic_syndrome" title="Myelodysplastic syndrome">myelodysplastic syndrome</a> phase, before developing into overt acute leukemia. Cyclophosphamide-induced leukemia will often involve complex <a href="/wiki/Cytogenetics" title="Cytogenetics">cytogenetics</a>, which carries a worse prognosis than <i>de novo</i> AML.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (May 2014)">citation needed</span></a></i>&#93;</sup>
</p>
<h2><span class="mw-headline" id="Pharmacology">Pharmacology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=12" title="Edit section: Pharmacology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Oral cyclophosphamide is rapidly absorbed and then converted by mixed-function <a href="/wiki/Oxidase" title="Oxidase">oxidase</a> <a href="/wiki/Enzyme" title="Enzyme">enzymes</a> (<a href="/wiki/Cytochrome_P450" title="Cytochrome P450">cytochrome P450</a> system) in the liver to active metabolites.<sup id="cite_ref-pmid4393764_37-0" class="reference"><a href="#cite_note-pmid4393764-37">&#91;37&#93;</a></sup><sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup> The main active metabolite is <a href="/wiki/4-Hydroxycyclophosphamide" title="4-Hydroxycyclophosphamide">4-hydroxycyclophosphamide</a>, which exists in <a href="/wiki/Chemical_equilibrium" title="Chemical equilibrium">equilibrium</a> with its <a href="/wiki/Tautomer" title="Tautomer">tautomer</a>, <a href="/wiki/Aldophosphamide" class="mw-redirect" title="Aldophosphamide">aldophosphamide</a>. Most of the aldophosphamide is then oxidised by the enzyme <a href="/wiki/Aldehyde_dehydrogenase" title="Aldehyde dehydrogenase">aldehyde dehydrogenase</a> (ALDH) to make <a href="/wiki/Carboxycyclophosphamide" title="Carboxycyclophosphamide">carboxycyclophosphamide</a>. A small proportion of aldophosphamide freely diffuses into cells, where it is decomposed into two compounds, phosphoramide mustard and acrolein.<sup id="cite_ref-pmid10803453_39-0" class="reference"><a href="#cite_note-pmid10803453-39">&#91;39&#93;</a></sup> The active metabolites of cyclophosphamide are highly protein bound and distributed to all tissues, are assumed to cross the <a href="/wiki/Placenta" title="Placenta">placenta</a> and are known to be present in <a href="/wiki/Breast_milk" title="Breast milk">breast milk</a>.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;40&#93;</a></sup>
</p><p>It is specifically in the oxazaphosphorine group of medications.<sup id="cite_ref-pmid_20446865_41-0" class="reference"><a href="#cite_note-pmid_20446865-41">&#91;41&#93;</a></sup>
</p><p>Cyclophosphamide metabolites are primarily excreted in the urine unchanged, and drug dosing should be appropriately adjusted in the setting of renal dysfunction.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">&#91;42&#93;</a></sup> Drugs altering hepatic microsomal enzyme activity (e.g., <a href="/wiki/Ethanol" title="Ethanol">alcohol</a>, <a href="/wiki/Barbiturates" class="mw-redirect" title="Barbiturates">barbiturates</a>, <a href="/wiki/Rifampicin" title="Rifampicin">rifampicin</a>, or <a href="/wiki/Phenytoin" title="Phenytoin">phenytoin</a>) may result in accelerated metabolism of cyclophosphamide into its active metabolites, increasing both pharmacologic and toxic effects of the drug; alternatively, drugs that inhibit hepatic microsomal enzymes (e.g. <a href="/wiki/Corticosteroids" class="mw-redirect" title="Corticosteroids">corticosteroids</a>, <a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressants</a>, or <a href="/wiki/Allopurinol" title="Allopurinol">allopurinol</a>) result in slower conversion of cyclophosphamide into its metabolites and consequently reduced therapeutic and toxic effects.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43">&#91;43&#93;</a></sup>
</p><p>Cyclophosphamide reduces plasma <a href="/wiki/Butyrylcholinesterase" title="Butyrylcholinesterase">pseudocholinesterase</a> activity and may result in prolonged <a href="/wiki/Neuromuscular_junction" title="Neuromuscular junction">neuromuscular blockade</a> when administered concurrently with <a href="/wiki/Succinylcholine" class="mw-redirect" title="Succinylcholine">succinylcholine</a>.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">&#91;44&#93;</a></sup><sup id="cite_ref-45" class="reference"><a href="#cite_note-45">&#91;45&#93;</a></sup> Tricyclic antidepressants and other <a href="/wiki/Anticholinergic" title="Anticholinergic">anticholinergic</a> agents can result in delayed bladder emptying and prolonged bladder exposure to acrolein.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (May 2014)">citation needed</span></a></i>&#93;</sup>
</p>
<h2><span class="mw-headline" id="Mechanism_of_action">Mechanism of action</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=13" title="Edit section: Mechanism of action">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The main effect of cyclophosphamide is due to its metabolite phosphoramide mustard. This metabolite is only formed in cells that have low levels of <a href="/wiki/ALDH" class="mw-redirect" title="ALDH">ALDH</a>. Phosphoramide mustard forms DNA crosslinks both between and within DNA strands at <a href="/wiki/Guanine" title="Guanine">guanine</a> N-7 positions (known as interstrand and intrastrand crosslinkages, respectively). This is irreversible and leads to cell <a href="/wiki/Apoptosis" title="Apoptosis">apoptosis</a>.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">&#91;46&#93;</a></sup>
</p><p>Cyclophosphamide has relatively little typical <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> toxicity as ALDHs are present in relatively large concentrations in <a href="/wiki/Pluripotential_hemopoietic_stem_cells" class="mw-redirect" title="Pluripotential hemopoietic stem cells">bone marrow stem cells</a>, <a href="/wiki/Liver" title="Liver">liver</a> and <a href="/wiki/Intestine" class="mw-redirect" title="Intestine">intestinal</a> <a href="/wiki/Epithelium" title="Epithelium">epithelium</a>. ALDHs protect these actively proliferating tissues against toxic effects of phosphoramide mustard and acrolein by converting <a href="/wiki/Aldophosphamide" class="mw-redirect" title="Aldophosphamide">aldophosphamide</a> to <a href="/wiki/Carboxycyclophosphamide" title="Carboxycyclophosphamide">carboxycyclophosphamide</a> that does not give rise to the toxic metabolites phosphoramide mustard and acrolein. This is because carboxycyclophosphamide cannot undergo β-elimination (the carboxylate acts as an electron-donating group, nullifying the potential for transformation), preventing nitrogen mustard activation and subsequent <a href="/wiki/Alkylation" title="Alkylation">alkylation</a>.<sup id="cite_ref-pmid19786984_26-1" class="reference"><a href="#cite_note-pmid19786984-26">&#91;26&#93;</a></sup><sup id="cite_ref-pmid2996550_47-0" class="reference"><a href="#cite_note-pmid2996550-47">&#91;47&#93;</a></sup><sup id="cite_ref-pmid1277209_48-0" class="reference"><a href="#cite_note-pmid1277209-48">&#91;48&#93;</a></sup>
</p><p>Cyclophosphamide induces beneficial <a href="/wiki/Immunomodulator" class="mw-redirect" title="Immunomodulator">immunomodulatory</a> effects in adaptive <a href="/wiki/Immunotherapy" title="Immunotherapy">immunotherapy</a>. Suggested mechanisms include:<sup id="cite_ref-49" class="reference"><a href="#cite_note-49">&#91;49&#93;</a></sup>
</p>
<ol><li>Elimination of T regulatory cells (CD4<sup>+</sup>CD25<sup>+</sup> T cells) in naive and tumor-bearing hosts</li>
<li>Induction of T cell growth factors, such as type I IFNs, and/or</li>
<li>Enhanced grafting of adoptively transferred, tumor-reactive effector T cells by the creation of an immunologic space niche.</li></ol>
<p>Thus, cyclophosphamide <a href="/wiki/Preconditioning_(adaptation)" title="Preconditioning (adaptation)">preconditioning</a> of recipient hosts (for donor T cells) has been used to enhance immunity in naïve hosts, and to enhance adoptive T cell immunotherapy regimens, as well as active <a href="/wiki/Vaccination" title="Vaccination">vaccination</a> strategies, inducing objective antitumor immunity.
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=14" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>As reported by O. M. Colvin in his study of the development of cyclophosphamide and its clinical applications,
</p>
<blockquote><p>Phosphoramide mustard, one of the principal toxic metabolites of cyclophosphamide, was synthesized and reported by Friedman and Seligman in 1954<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">&#91;50&#93;</a></sup> …It was postulated that the presence of the phosphate bond to the nitrogen atom could inactivate the nitrogen mustard moiety, but the phosphate bond would be cleaved in gastric cancers and other tumors which had a high phosphamidase content. However, in studies carried out after the clinical efficacy of cyclophosphamide was demonstrated, phosphoramide mustard proved to be cytotoxic <i>in vitro</i> (footnote omitted), but to have a low therapeutic index <i>in vivo</i>.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51">&#91;51&#93;</a></sup></p></blockquote>
<p>Cyclophosphamide and the related <a href="/wiki/Nitrogen_mustard" title="Nitrogen mustard">nitrogen mustard</a>–derived alkylating agent <a href="/wiki/Ifosfamide" title="Ifosfamide">ifosfamide</a> were developed by Norbert Brock and ASTA (now <a href="/wiki/Baxter_International" title="Baxter International">Baxter</a> Oncology).<sup id="cite_ref-52" class="reference"><a href="#cite_note-52">&#91;52&#93;</a></sup>  Brock and his team synthesised and screened more than 1,000 candidate oxazaphosphorine compounds.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53">&#91;53&#93;</a></sup> They converted the base nitrogen mustard into a nontoxic "transport form". This transport form was a prodrug, subsequently <a href="/wiki/Active_transport" title="Active transport">actively transported</a> into cancer cells. Once in the cells, the prodrug was <a href="/wiki/Enzyme" title="Enzyme">enzymatically</a> converted into the active, toxic form. The first clinical trials were published at the end of the 1950s.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">&#91;54&#93;</a></sup><sup id="cite_ref-55" class="reference"><a href="#cite_note-55">&#91;55&#93;</a></sup><sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup> In 1959 it became the eighth cytotoxic anticancer agent to be approved by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a>.<sup id="cite_ref-pmid19786984_26-2" class="reference"><a href="#cite_note-pmid19786984-26">&#91;26&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=15" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The abbreviation CP is common, although abbreviating drug names is not <a href="/wiki/Best_practice" title="Best practice">best practice</a> in medicine.<sup id="cite_ref-ISMP_list_do_not_abbreviate_57-0" class="reference"><a href="#cite_note-ISMP_list_do_not_abbreviate-57">&#91;57&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=16" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Because of its impact on the immune system, it is used in animal studies. Rodents are injected intraperitoneally with either a single dose of 150&#160;mg/kg or two doses (150 and 100&#160;mg/kg) spread over two days.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58">&#91;58&#93;</a></sup> This can be used for applications such as:
</p>
<ul><li>The <a href="/wiki/United_States_Environmental_Protection_Agency" title="United States Environmental Protection Agency">EPA</a> may be concerned about potential human pathogenicity of an engineered microbe when conducting an MCAN review. Particularly for bacteria with potential consumer exposure they require testing of the microbe on immuno-compromised rats.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">&#91;59&#93;</a></sup></li>
<li>Cyclophosphamide provides a positive control when studying immune-response of a new drug.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60">&#91;60&#93;</a></sup></li></ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=17" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist reflist-columns references-column-width" style="column-width: 32em;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1067248974">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.oxforddictionaries.com/definition/english/cyclophosphamide">"cyclophosphamide – definition of cyclophosphamide in English from the Oxford dictionary"</a>. <a href="/wiki/OxfordDictionaries.com" class="mw-redirect" title="OxfordDictionaries.com">OxfordDictionaries.com</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2016-01-20</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=cyclophosphamide+%E2%80%93+definition+of+cyclophosphamide+in+English+from+the+Oxford+dictionary&amp;rft.pub=OxfordDictionaries.com&amp;rft_id=https%3A%2F%2Fwww.oxforddictionaries.com%2Fdefinition%2Fenglish%2Fcyclophosphamide&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.merriam-webster.com/dictionary/cyclophosphamide">"cyclophosphamide"</a>. <i><a href="/wiki/Merriam-Webster" title="Merriam-Webster">Merriam-Webster Dictionary</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Merriam-Webster+Dictionary&amp;rft.atitle=cyclophosphamide&amp;rft_id=https%3A%2F%2Fwww.merriam-webster.com%2Fdictionary%2Fcyclophosphamide&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.cancer.gov/drugdictionary/?CdrID=39748">"NCI Drug Dictionary"</a>. <i>National Cancer Institute</i>. 2 February 2011. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150425042348/http://www.cancer.gov/drugdictionary?CdrID=39748">Archived</a> from the original on 25 April 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">20 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Cancer+Institute&amp;rft.atitle=NCI+Drug+Dictionary&amp;rft.date=2011-02-02&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fdrugdictionary%2F%3FCdrID%3D39748&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-AHFS2016-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-AHFS2016_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AHFS2016_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AHFS2016_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AHFS2016_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-AHFS2016_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-AHFS2016_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-AHFS2016_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-AHFS2016_4-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-AHFS2016_4-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-AHFS2016_4-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/monograph/cyclophosphamide.html">"Cyclophosphamide"</a>. The American Society of Health-System Pharmacists. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170102075231/https://www.drugs.com/monograph/cyclophosphamide.html">Archived</a> from the original on 2 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">8 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Cyclophosphamide&amp;rft.pub=The+American+Society+of+Health-System+Pharmacists&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fcyclophosphamide.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-Pagnoux-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pagnoux_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pagnoux_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPagnoux2016" class="citation journal cs1">Pagnoux C (September 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5058451">"Updates in ANCA-associated vasculitis"</a>. <i>European Journal of Rheumatology</i>. <b>3</b> (3): 122–133. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.5152%2Feurjrheum.2015.0043">10.5152/eurjrheum.2015.0043</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5058451">5058451</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27733943">27733943</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Rheumatology&amp;rft.atitle=Updates+in+ANCA-associated+vasculitis&amp;rft.volume=3&amp;rft.issue=3&amp;rft.pages=122-133&amp;rft.date=2016-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5058451%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27733943&amp;rft_id=info%3Adoi%2F10.5152%2Feurjrheum.2015.0043&amp;rft.aulast=Pagnoux&amp;rft.aufirst=C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5058451&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-WHO21st-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-WHO21st_6-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1"><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//hdl.handle.net/10665%2F325771">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=World+Health+Organization+model+list+of+essential+medicines%3A+21st+list+2019&amp;rft.place=Geneva&amp;rft.pub=World+Health+Organization&amp;rft.date=2019&amp;rft_id=info%3Ahdl%2F10665%2F325771&amp;rft.au=World+Health+Organization&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-MD-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-MD_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MD_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MD_7-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBrayfield,_A2017" class="citation web cs1">Brayfield, A, ed. (9 January 2017). <a rel="nofollow" class="external text" href="https://www.medicinescomplete.com/mc/martindale/current/1825-k.htm">"Cyclophosphamide: Martindale: The Complete Drug Reference"</a>. <i>MedicinesComplete</i>. London, UK: Pharmaceutical Press<span class="reference-accessdate">. Retrieved <span class="nowrap">12 August</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MedicinesComplete&amp;rft.atitle=Cyclophosphamide%3A+Martindale%3A+The+Complete+Drug+Reference&amp;rft.date=2017-01-09&amp;rft_id=https%3A%2F%2Fwww.medicinescomplete.com%2Fmc%2Fmartindale%2Fcurrent%2F1825-k.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation book cs1"><i>Brenner &amp; Rector's The Kidney</i> (11th&#160;ed.). Philadelphia: Elsevier. 2020. pp.&#160;1007–1091. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-323-53265-5" title="Special:BookSources/978-0-323-53265-5"><bdi>978-0-323-53265-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Brenner+%26+Rector%27s+The+Kidney&amp;rft.place=Philadelphia&amp;rft.pages=1007-1091&amp;rft.edition=11th&amp;rft.pub=Elsevier&amp;rft.date=2020&amp;rft.isbn=978-0-323-53265-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDeVriezeHurley2019" class="citation book cs1">DeVrieze BW, Hurley JA (2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/books/NBK459291/">"Goodpasture Syndrome (Anti-glomerular Basement Membrane Antibody Disease)"</a>. <i>StatPearls</i>. Treasure Island, USA: StatPearls Publishing. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29083697">29083697</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Goodpasture+Syndrome+%28Anti-glomerular+Basement+Membrane+Antibody+Disease%29&amp;rft.btitle=StatPearls&amp;rft.place=Treasure+Island%2C+USA&amp;rft.pub=StatPearls+Publishing&amp;rft.date=2019&amp;rft_id=info%3Apmid%2F29083697&amp;rft.aulast=DeVrieze&amp;rft.aufirst=BW&amp;rft.au=Hurley%2C+JA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK459291%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLa_MantiaMilaneseMascoliD&#39;Amico2007" class="citation journal cs1">La Mantia, L.; Milanese, C.; Mascoli, N.; D'Amico, R.; Weinstock-Guttman, B. (2007-01-24). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC8078225">"Cyclophosphamide for multiple sclerosis"</a>. <i>Cochrane Database of Systematic Reviews</i> (1): CD002819. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD002819.pub2">10.1002/14651858.CD002819.pub2</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1469-493X">1469-493X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC8078225">8078225</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17253481">17253481</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Cyclophosphamide+for+multiple+sclerosis&amp;rft.issue=1&amp;rft.pages=CD002819&amp;rft.date=2007-01-24&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8078225%23id-name%3DPMC&amp;rft.issn=1469-493X&amp;rft_id=info%3Apmid%2F17253481&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002819.pub2&amp;rft.aulast=La+Mantia&amp;rft.aufirst=L.&amp;rft.au=Milanese%2C+C.&amp;rft.au=Mascoli%2C+N.&amp;rft.au=D%27Amico%2C+R.&amp;rft.au=Weinstock-Guttman%2C+B.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8078225&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDavisReimold2017" class="citation journal cs1">Davis LS, Reimold AM (April 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5850311">"Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus"</a>. <i>Rheumatology</i>. <b>56</b> (suppl_1): i100–i113. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Frheumatology%2Fkew417">10.1093/rheumatology/kew417</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5850311">5850311</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28375452">28375452</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Rheumatology&amp;rft.atitle=Research+and+therapeutics-traditional+and+emerging+therapies+in+systemic+lupus+erythematosus&amp;rft.volume=56&amp;rft.issue=suppl_1&amp;rft.pages=i100-i113&amp;rft.date=2017-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5850311%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28375452&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fkew417&amp;rft.aulast=Davis&amp;rft.aufirst=LS&amp;rft.au=Reimold%2C+AM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5850311&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSinghHossainKotbWells2016" class="citation journal cs1">Singh, Jasvinder A.; Hossain, Alomgir; Kotb, Ahmed; Wells, George A. (2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5020478">"Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis"</a>. <i>Systematic Reviews</i>. <b>5</b> (1): 155. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs13643-016-0328-z">10.1186/s13643-016-0328-z</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/2046-4053">2046-4053</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5020478">5020478</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27619512">27619512</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Systematic+Reviews&amp;rft.atitle=Comparative+effectiveness+of+immunosuppressive+drugs+and+corticosteroids+for+lupus+nephritis%3A+a+systematic+review+and+network+meta-analysis&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=155&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5020478%23id-name%3DPMC&amp;rft.issn=2046-4053&amp;rft_id=info%3Apmid%2F27619512&amp;rft_id=info%3Adoi%2F10.1186%2Fs13643-016-0328-z&amp;rft.aulast=Singh&amp;rft.aufirst=Jasvinder+A.&amp;rft.au=Hossain%2C+Alomgir&amp;rft.au=Kotb%2C+Ahmed&amp;rft.au=Wells%2C+George+A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5020478&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGertz2014" class="citation journal cs1">Gertz MA (December 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fajh.23828">"Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment"</a>. <i>American Journal of Hematology</i>. <b>89</b> (12): 1132–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fajh.23828">10.1002/ajh.23828</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25407896">25407896</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:85480421">85480421</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Hematology&amp;rft.atitle=Immunoglobulin+light+chain+amyloidosis%3A+2014+update+on+diagnosis%2C+prognosis%2C+and+treatment&amp;rft.volume=89&amp;rft.issue=12&amp;rft.pages=1132-40&amp;rft.date=2014-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A85480421%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25407896&amp;rft_id=info%3Adoi%2F10.1002%2Fajh.23828&amp;rft.aulast=Gertz&amp;rft.aufirst=MA&amp;rft_id=%2F%2Fdoi.org%2F10.1002%252Fajh.23828&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFOr-GevaReisner2016" class="citation journal cs1">Or-Geva N, Reisner Y (March 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fbjh.13868">"The evolution of T-cell depletion in haploidentical stem-cell transplantation"</a>. <i>British Journal of Haematology</i>. <b>172</b> (5): 667–84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fbjh.13868">10.1111/bjh.13868</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26684279">26684279</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:1093277">1093277</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Haematology&amp;rft.atitle=The+evolution+of+T-cell+depletion+in+haploidentical+stem-cell+transplantation&amp;rft.volume=172&amp;rft.issue=5&amp;rft.pages=667-84&amp;rft.date=2016-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A1093277%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26684279&amp;rft_id=info%3Adoi%2F10.1111%2Fbjh.13868&amp;rft.aulast=Or-Geva&amp;rft.aufirst=N&amp;rft.au=Reisner%2C+Y&amp;rft_id=%2F%2Fdoi.org%2F10.1111%252Fbjh.13868&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFuchs2015" class="citation journal cs1 cs1-prop-long-vol">Fuchs EJ (June 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4634886">"HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide"</a>. <i>Bone Marrow Transplantation</i>. 50 Suppl 2: S31–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fbmt.2015.92">10.1038/bmt.2015.92</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4634886">4634886</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26039204">26039204</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bone+Marrow+Transplantation&amp;rft.atitle=HLA-haploidentical+blood+or+marrow+transplantation+with+high-dose%2C+post-transplantation+cyclophosphamide&amp;rft.volume=50+Suppl+2&amp;rft.pages=S31-6&amp;rft.date=2015-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4634886%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26039204&amp;rft_id=info%3Adoi%2F10.1038%2Fbmt.2015.92&amp;rft.aulast=Fuchs&amp;rft.aufirst=EJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4634886&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRobinsonO&#39;DonnellFuchsLuznik2016" class="citation journal cs1">Robinson TM, O'Donnell PV, Fuchs EJ, Luznik L (April 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4806368">"Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide"</a>. <i>Seminars in Hematology</i>. <b>53</b> (2): 90–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.seminhematol.2016.01.005">10.1053/j.seminhematol.2016.01.005</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4806368">4806368</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27000732">27000732</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Hematology&amp;rft.atitle=Haploidentical+bone+marrow+and+stem+cell+transplantation%3A+experience+with+post-transplantation+cyclophosphamide&amp;rft.volume=53&amp;rft.issue=2&amp;rft.pages=90-7&amp;rft.date=2016-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4806368%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27000732&amp;rft_id=info%3Adoi%2F10.1053%2Fj.seminhematol.2016.01.005&amp;rft.aulast=Robinson&amp;rft.aufirst=TM&amp;rft.au=O%27Donnell%2C+PV&amp;rft.au=Fuchs%2C+EJ&amp;rft.au=Luznik%2C+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4806368&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFEnnsRoederChanAli-Khan_Catts1999" class="citation journal cs1">Enns GM, Roeder E, Chan RT, Ali-Khan Catts Z, Cox VA, Golabi M (September 1999). "Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?". <i>American Journal of Medical Genetics</i>. <b>86</b> (3): 237–41. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F%28SICI%291096-8628%2819990917%2986%3A3%3C237%3A%3AAID-AJMG8%3E3.0.CO%3B2-V">10.1002/(SICI)1096-8628(19990917)86:3&#60;237::AID-AJMG8&#62;3.0.CO;2-V</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/10482872">10482872</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Medical+Genetics&amp;rft.atitle=Apparent+cyclophosphamide+%28cytoxan%29+embryopathy%3A+a+distinct+phenotype%3F&amp;rft.volume=86&amp;rft.issue=3&amp;rft.pages=237-41&amp;rft.date=1999-09&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291096-8628%2819990917%2986%3A3%3C237%3A%3AAID-AJMG8%3E3.0.CO%3B2-V&amp;rft_id=info%3Apmid%2F10482872&amp;rft.aulast=Enns&amp;rft.aufirst=GM&amp;rft.au=Roeder%2C+E&amp;rft.au=Chan%2C+RT&amp;rft.au=Ali-Khan+Catts%2C+Z&amp;rft.au=Cox%2C+VA&amp;rft.au=Golabi%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSinghFriesWilliamsZatarain1991" class="citation journal cs1">Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch DA (February 1991). "Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis". <i>The Journal of Rheumatology</i>. <b>18</b> (2): 188–94. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/1673721">1673721</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Rheumatology&amp;rft.atitle=Toxicity+profiles+of+disease+modifying+antirheumatic+drugs+in+rheumatoid+arthritis&amp;rft.volume=18&amp;rft.issue=2&amp;rft.pages=188-94&amp;rft.date=1991-02&amp;rft_id=info%3Apmid%2F1673721&amp;rft.aulast=Singh&amp;rft.aufirst=G&amp;rft.au=Fries%2C+JF&amp;rft.au=Williams%2C+CA&amp;rft.au=Zatarain%2C+E&amp;rft.au=Spitz%2C+P&amp;rft.au=Bloch%2C+DA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLohrmann1984" class="citation journal cs1">Lohrmann HP (1984). "The problem of permanent bone marrow damage after cytotoxic drug treatment". <i>Oncology</i>. <b>41</b> (3): 180–4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000225819">10.1159/000225819</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/6374556">6374556</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncology&amp;rft.atitle=The+problem+of+permanent+bone+marrow+damage+after+cytotoxic+drug+treatment&amp;rft.volume=41&amp;rft.issue=3&amp;rft.pages=180-4&amp;rft.date=1984&amp;rft_id=info%3Adoi%2F10.1159%2F000225819&amp;rft_id=info%3Apmid%2F6374556&amp;rft.aulast=Lohrmann&amp;rft.aufirst=HP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSinghHossainKotbWells2016" class="citation journal cs1">Singh JA, Hossain A, Kotb A, Wells G (September 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5022202">"Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis"</a>. <i>BMC Medicine</i>. <b>14</b> (1): 137. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs12916-016-0673-8">10.1186/s12916-016-0673-8</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5022202">5022202</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27623861">27623861</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Medicine&amp;rft.atitle=Risk+of+serious+infections+with+immunosuppressive+drugs+and+glucocorticoids+for+lupus+nephritis%3A+a+systematic+review+and+network+meta-analysis&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=137&amp;rft.date=2016-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5022202%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27623861&amp;rft_id=info%3Adoi%2F10.1186%2Fs12916-016-0673-8&amp;rft.aulast=Singh&amp;rft.aufirst=JA&amp;rft.au=Hossain%2C+A&amp;rft.au=Kotb%2C+A&amp;rft.au=Wells%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5022202&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTwohigMatthay1990" class="citation journal cs1">Twohig KJ, Matthay RA (March 1990). "Pulmonary effects of cytotoxic agents other than bleomycin". <i>Clinics in Chest Medicine</i>. <b>11</b> (1): 31–54. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0272-5231%2821%2900670-5">10.1016/S0272-5231(21)00670-5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/1691069">1691069</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinics+in+Chest+Medicine&amp;rft.atitle=Pulmonary+effects+of+cytotoxic+agents+other+than+bleomycin&amp;rft.volume=11&amp;rft.issue=1&amp;rft.pages=31-54&amp;rft.date=1990-03&amp;rft_id=info%3Adoi%2F10.1016%2FS0272-5231%2821%2900670-5&amp;rft_id=info%3Apmid%2F1691069&amp;rft.aulast=Twohig&amp;rft.aufirst=KJ&amp;rft.au=Matthay%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMalikMyersDeRemeeSpecks1996" class="citation journal cs1">Malik SW, Myers JL, DeRemee RA, Specks U (December 1996). "Lung toxicity associated with cyclophosphamide use. Two distinct patterns". <i>American Journal of Respiratory and Critical Care Medicine</i>. <b>154</b> (6 Pt 1): 1851–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1164%2Fajrccm.154.6.8970380">10.1164/ajrccm.154.6.8970380</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8970380">8970380</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Respiratory+and+Critical+Care+Medicine&amp;rft.atitle=Lung+toxicity+associated+with+cyclophosphamide+use.+Two+distinct+patterns&amp;rft.volume=154&amp;rft.issue=6+Pt+1&amp;rft.pages=1851-6&amp;rft.date=1996-12&amp;rft_id=info%3Adoi%2F10.1164%2Fajrccm.154.6.8970380&amp;rft_id=info%3Apmid%2F8970380&amp;rft.aulast=Malik&amp;rft.aufirst=SW&amp;rft.au=Myers%2C+JL&amp;rft.au=DeRemee%2C+RA&amp;rft.au=Specks%2C+U&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFloydNguyenLobinsBashir2005" class="citation journal cs1">Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC (October 2005). "Cardiotoxicity of cancer therapy". <i>Journal of Clinical Oncology</i>. <b>23</b> (30): 7685–96. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1200%2FJCO.2005.08.789">10.1200/JCO.2005.08.789</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16234530">16234530</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=Cardiotoxicity+of+cancer+therapy&amp;rft.volume=23&amp;rft.issue=30&amp;rft.pages=7685-96&amp;rft.date=2005-10&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2005.08.789&amp;rft_id=info%3Apmid%2F16234530&amp;rft.aulast=Floyd&amp;rft.aufirst=JD&amp;rft.au=Nguyen%2C+DT&amp;rft.au=Lobins%2C+RL&amp;rft.au=Bashir%2C+Q&amp;rft.au=Doll%2C+DC&amp;rft.au=Perry%2C+MC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBresslerHuston1985" class="citation journal cs1">Bressler RB, Huston DP (March 1985). "Water intoxication following moderate-dose intravenous cyclophosphamide". <i>Archives of Internal Medicine</i>. <b>145</b> (3): 548–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchinte.145.3.548">10.1001/archinte.145.3.548</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/3977522">3977522</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.atitle=Water+intoxication+following+moderate-dose+intravenous+cyclophosphamide&amp;rft.volume=145&amp;rft.issue=3&amp;rft.pages=548-9&amp;rft.date=1985-03&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.145.3.548&amp;rft_id=info%3Apmid%2F3977522&amp;rft.aulast=Bressler&amp;rft.aufirst=RB&amp;rft.au=Huston%2C+DP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSalidoMacarronHernández-GarcíaD&#39;Cruz2003" class="citation journal cs1">Salido M, Macarron P, Hernández-García C, D'Cruz DP, Khamashta MA, Hughes GR (2003). "Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus". <i>Lupus</i>. <b>12</b> (8): 636–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1191%2F0961203303lu421cr">10.1191/0961203303lu421cr</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12945725">12945725</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:26125211">26125211</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lupus&amp;rft.atitle=Water+intoxication+induced+by+low-dose+cyclophosphamide+in+two+patients+with+systemic+lupus+erythematosus&amp;rft.volume=12&amp;rft.issue=8&amp;rft.pages=636-9&amp;rft.date=2003&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A26125211%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12945725&amp;rft_id=info%3Adoi%2F10.1191%2F0961203303lu421cr&amp;rft.aulast=Salido&amp;rft.aufirst=M&amp;rft.au=Macarron%2C+P&amp;rft.au=Hern%C3%A1ndez-Garc%C3%ADa%2C+C&amp;rft.au=D%27Cruz%2C+DP&amp;rft.au=Khamashta%2C+MA&amp;rft.au=Hughes%2C+GR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid19786984-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19786984_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19786984_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid19786984_26-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFEmadiJonesBrodsky2009" class="citation journal cs1">Emadi A, Jones RJ, Brodsky RA (November 2009). "Cyclophosphamide and cancer: golden anniversary". <i>Nature Reviews. Clinical Oncology</i>. <b>6</b> (11): 638–47. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrclinonc.2009.146">10.1038/nrclinonc.2009.146</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19786984">19786984</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:18219134">18219134</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Clinical+Oncology&amp;rft.atitle=Cyclophosphamide+and+cancer%3A+golden+anniversary&amp;rft.volume=6&amp;rft.issue=11&amp;rft.pages=638-47&amp;rft.date=2009-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A18219134%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19786984&amp;rft_id=info%3Adoi%2F10.1038%2Fnrclinonc.2009.146&amp;rft.aulast=Emadi&amp;rft.aufirst=A&amp;rft.au=Jones%2C+RJ&amp;rft.au=Brodsky%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMonachArnoldMerkel2010" class="citation journal cs1">Monach PA, Arnold LM, Merkel PA (January 2010). "Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review". <i>Arthritis and Rheumatism</i>. <b>62</b> (1): 9–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fart.25061">10.1002/art.25061</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20039416">20039416</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arthritis+and+Rheumatism&amp;rft.atitle=Incidence+and+prevention+of+bladder+toxicity+from+cyclophosphamide+in+the+treatment+of+rheumatic+diseases%3A+a+data-driven+review&amp;rft.volume=62&amp;rft.issue=1&amp;rft.pages=9-21&amp;rft.date=2010-01&amp;rft_id=info%3Adoi%2F10.1002%2Fart.25061&amp;rft_id=info%3Apmid%2F20039416&amp;rft.aulast=Monach&amp;rft.aufirst=PA&amp;rft.au=Arnold%2C+LM&amp;rft.au=Merkel%2C+PA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBoumpasAustinVaughnKlippel1992" class="citation journal cs1">Boumpas DT, Austin HA, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE (September 1992). <a rel="nofollow" class="external text" href="https://zenodo.org/record/1258313">"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis"</a>. <i>Lancet</i>. <b>340</b> (8822): 741–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0140-6736%2892%2992292-n">10.1016/0140-6736(92)92292-n</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/1356175">1356175</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8800101">8800101</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Controlled+trial+of+pulse+methylprednisolone+versus+two+regimens+of+pulse+cyclophosphamide+in+severe+lupus+nephritis&amp;rft.volume=340&amp;rft.issue=8822&amp;rft.pages=741-5&amp;rft.date=1992-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8800101%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F1356175&amp;rft_id=info%3Adoi%2F10.1016%2F0140-6736%2892%2992292-n&amp;rft.aulast=Boumpas&amp;rft.aufirst=DT&amp;rft.au=Austin%2C+HA&amp;rft.au=Vaughn%2C+EM&amp;rft.au=Klippel%2C+JH&amp;rft.au=Steinberg%2C+AD&amp;rft.au=Yarboro%2C+CH&amp;rft.au=Balow%2C+JE&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1258313&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPryorBolognaKahl1996" class="citation journal cs1">Pryor BD, Bologna SG, Kahl LE (September 1996). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fart.1780390906">"Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus"</a>. <i>Arthritis and Rheumatism</i>. <b>39</b> (9): 1475–82. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fart.1780390906">10.1002/art.1780390906</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8814058">8814058</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arthritis+and+Rheumatism&amp;rft.atitle=Risk+factors+for+serious+infection+during+treatment+with+cyclophosphamide+and+high-dose+corticosteroids+for+systemic+lupus+erythematosus&amp;rft.volume=39&amp;rft.issue=9&amp;rft.pages=1475-82&amp;rft.date=1996-09&amp;rft_id=info%3Adoi%2F10.1002%2Fart.1780390906&amp;rft_id=info%3Apmid%2F8814058&amp;rft.aulast=Pryor&amp;rft.aufirst=BD&amp;rft.au=Bologna%2C+SG&amp;rft.au=Kahl%2C+LE&amp;rft_id=%2F%2Fdoi.org%2F10.1002%252Fart.1780390906&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSuryaprasadStone2008" class="citation journal cs1">Suryaprasad A, Stone JH (July 2008). "When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases". <i>Arthritis and Rheumatism</i>. <b>59</b> (7): 1034–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fart.23822">10.1002/art.23822</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18576286">18576286</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arthritis+and+Rheumatism&amp;rft.atitle=When+is+it+safe+to+stop+Pneumocystis+jiroveci+pneumonia+prophylaxis%3F+Insights+from+three+cases+complicating+autoimmune+diseases&amp;rft.volume=59&amp;rft.issue=7&amp;rft.pages=1034-9&amp;rft.date=2008-07&amp;rft_id=info%3Adoi%2F10.1002%2Fart.23822&amp;rft_id=info%3Apmid%2F18576286&amp;rft.aulast=Suryaprasad&amp;rft.aufirst=A&amp;rft.au=Stone%2C+JH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-Kronbichler2015-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kronbichler2015_31-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKronbichlerJayneMayer2015" class="citation journal cs1">Kronbichler A, Jayne DR, Mayer G (March 2015). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Feci.12410">"Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis"</a>. <i>European Journal of Clinical Investigation</i> (Review). <b>45</b> (3): 346–68. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Feci.12410">10.1111/eci.12410</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25627555">25627555</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:870510">870510</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Clinical+Investigation&amp;rft.atitle=Frequency%2C+risk+factors+and+prophylaxis+of+infection+in+ANCA-associated+vasculitis&amp;rft.volume=45&amp;rft.issue=3&amp;rft.pages=346-68&amp;rft.date=2015-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A870510%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25627555&amp;rft_id=info%3Adoi%2F10.1111%2Feci.12410&amp;rft.aulast=Kronbichler&amp;rft.aufirst=A&amp;rft.au=Jayne%2C+DR&amp;rft.au=Mayer%2C+G&amp;rft_id=%2F%2Fdoi.org%2F10.1111%252Feci.12410&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBalowAustinTsokosAntonovych1987" class="citation journal cs1">Balow JE, Austin HA, Tsokos GC, Antonovych TT, Steinberg AD, Klippel JH (January 1987). "NIH conference. Lupus nephritis". <i>Annals of Internal Medicine</i>. <b>106</b> (1): 79–94. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.7326%2F0003-4819-106-1-79">10.7326/0003-4819-106-1-79</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/3789582">3789582</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=NIH+conference.+Lupus+nephritis&amp;rft.volume=106&amp;rft.issue=1&amp;rft.pages=79-94&amp;rft.date=1987-01&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-106-1-79&amp;rft_id=info%3Apmid%2F3789582&amp;rft.aulast=Balow&amp;rft.aufirst=JE&amp;rft.au=Austin%2C+HA&amp;rft.au=Tsokos%2C+GC&amp;rft.au=Antonovych%2C+TT&amp;rft.au=Steinberg%2C+AD&amp;rft.au=Klippel%2C+JH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPeritiMazzeiMini2002" class="citation journal cs1">Periti P, Mazzei T, Mini E (2002). "Clinical pharmacokinetics of depot leuprorelin". <i>Clinical Pharmacokinetics</i>. <b>41</b> (7): 485–504. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F00003088-200241070-00003">10.2165/00003088-200241070-00003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12083977">12083977</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:10873321">10873321</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Pharmacokinetics&amp;rft.atitle=Clinical+pharmacokinetics+of+depot+leuprorelin&amp;rft.volume=41&amp;rft.issue=7&amp;rft.pages=485-504&amp;rft.date=2002&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A10873321%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12083977&amp;rft_id=info%3Adoi%2F10.2165%2F00003088-200241070-00003&amp;rft.aulast=Periti&amp;rft.aufirst=P&amp;rft.au=Mazzei%2C+T&amp;rft.au=Mini%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBernatskyClarkeSuissa2008" class="citation journal cs1">Bernatsky S, Clarke AE, Suissa S (February 2008). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchinternmed.2007.107">"Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis"</a>. <i>Archives of Internal Medicine</i>. <b>168</b> (4): 378–81. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchinternmed.2007.107">10.1001/archinternmed.2007.107</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18299492">18299492</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.atitle=Hematologic+malignant+neoplasms+after+drug+exposure+in+rheumatoid+arthritis&amp;rft.volume=168&amp;rft.issue=4&amp;rft.pages=378-81&amp;rft.date=2008-02&amp;rft_id=info%3Adoi%2F10.1001%2Farchinternmed.2007.107&amp;rft_id=info%3Apmid%2F18299492&amp;rft.aulast=Bernatsky&amp;rft.aufirst=S&amp;rft.au=Clarke%2C+AE&amp;rft.au=Suissa%2C+S&amp;rft_id=%2F%2Fdoi.org%2F10.1001%252Farchinternmed.2007.107&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRadisKahlBakerWasko1995" class="citation journal cs1">Radis CD, Kahl LE, Baker GL, Wasko MC, Cash JM, Gallatin A, Stolzer BL, Agarwal AK, Medsger TA, Kwoh CK (August 1995). "Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study". <i>Arthritis and Rheumatism</i>. <b>38</b> (8): 1120–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fart.1780380815">10.1002/art.1780380815</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/7639809">7639809</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arthritis+and+Rheumatism&amp;rft.atitle=Effects+of+cyclophosphamide+on+the+development+of+malignancy+and+on+long-term+survival+of+patients+with+rheumatoid+arthritis.+A+20-year+followup+study&amp;rft.volume=38&amp;rft.issue=8&amp;rft.pages=1120-7&amp;rft.date=1995-08&amp;rft_id=info%3Adoi%2F10.1002%2Fart.1780380815&amp;rft_id=info%3Apmid%2F7639809&amp;rft.aulast=Radis&amp;rft.aufirst=CD&amp;rft.au=Kahl%2C+LE&amp;rft.au=Baker%2C+GL&amp;rft.au=Wasko%2C+MC&amp;rft.au=Cash%2C+JM&amp;rft.au=Gallatin%2C+A&amp;rft.au=Stolzer%2C+BL&amp;rft.au=Agarwal%2C+AK&amp;rft.au=Medsger%2C+TA&amp;rft.au=Kwoh%2C+CK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLarson2007" class="citation journal cs1">Larson RA (2007). <a rel="nofollow" class="external text" href="https://doi.org/10.1182%2Fasheducation-2007.1.453">"Etiology and management of therapy-related myeloid leukemia"</a>. <i>Hematology. American Society of Hematology. Education Program</i>. <b>2007</b>: 453–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1182%2Fasheducation-2007.1.453">10.1182/asheducation-2007.1.453</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18024664">18024664</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hematology.+American+Society+of+Hematology.+Education+Program&amp;rft.atitle=Etiology+and+management+of+therapy-related+myeloid+leukemia&amp;rft.volume=2007&amp;rft.pages=453-9&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2007.1.453&amp;rft_id=info%3Apmid%2F18024664&amp;rft.aulast=Larson&amp;rft.aufirst=RA&amp;rft_id=%2F%2Fdoi.org%2F10.1182%252Fasheducation-2007.1.453&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid4393764-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid4393764_37-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCohenJao1970" class="citation journal cs1">Cohen JL, Jao JY (August 1970). <a rel="nofollow" class="external text" href="http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&amp;pmid=4393764">"Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat"</a>. <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>174</b> (2): 206–10. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/4393764">4393764</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;rft.atitle=Enzymatic+basis+of+cyclophosphamide+activation+by+hepatic+microsomes+of+the+rat&amp;rft.volume=174&amp;rft.issue=2&amp;rft.pages=206-10&amp;rft.date=1970-08&amp;rft_id=info%3Apmid%2F4393764&amp;rft.aulast=Cohen&amp;rft.aufirst=JL&amp;rft.au=Jao%2C+JY&amp;rft_id=http%3A%2F%2Fjpet.aspetjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D4393764&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHuttunenRaunioRautio2011" class="citation journal cs1">Huttunen KM, Raunio H, Rautio J (September 2011). "Prodrugs--from serendipity to rational design". <i>Pharmacological Reviews</i>. <b>63</b> (3): 750–71. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1124%2Fpr.110.003459">10.1124/pr.110.003459</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21737530">21737530</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25381232">25381232</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacological+Reviews&amp;rft.atitle=Prodrugs--from+serendipity+to+rational+design&amp;rft.volume=63&amp;rft.issue=3&amp;rft.pages=750-71&amp;rft.date=2011-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25381232%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21737530&amp;rft_id=info%3Adoi%2F10.1124%2Fpr.110.003459&amp;rft.aulast=Huttunen&amp;rft.aufirst=KM&amp;rft.au=Raunio%2C+H&amp;rft.au=Rautio%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid10803453-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10803453_39-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBoddyYule2000" class="citation journal cs1">Boddy AV, Yule SM (April 2000). "Metabolism and pharmacokinetics of oxazaphosphorines". <i>Clinical Pharmacokinetics</i>. <b>38</b> (4): 291–304. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F00003088-200038040-00001">10.2165/00003088-200038040-00001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/10803453">10803453</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39787288">39787288</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Pharmacokinetics&amp;rft.atitle=Metabolism+and+pharmacokinetics+of+oxazaphosphorines&amp;rft.volume=38&amp;rft.issue=4&amp;rft.pages=291-304&amp;rft.date=2000-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39787288%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10803453&amp;rft_id=info%3Adoi%2F10.2165%2F00003088-200038040-00001&amp;rft.aulast=Boddy&amp;rft.aufirst=AV&amp;rft.au=Yule%2C+SM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWiernikDuncan1971" class="citation journal cs1">Wiernik PH, Duncan JH (May 1971). "Cyclophosphamide in human milk". <i>Lancet</i>. <b>1</b> (7705): 912. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0140-6736%2871%2992474-3">10.1016/s0140-6736(71)92474-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/4102054">4102054</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Cyclophosphamide+in+human+milk&amp;rft.volume=1&amp;rft.issue=7705&amp;rft.pages=912&amp;rft.date=1971-05&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2871%2992474-3&amp;rft_id=info%3Apmid%2F4102054&amp;rft.aulast=Wiernik&amp;rft.aufirst=PH&amp;rft.au=Duncan%2C+JH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid_20446865-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid_20446865_41-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGiraud2010" class="citation cs2">Giraud, B;  et&#160;al. (2010), "Oxazaphosphorines: new therapeutic strategies for an old class of drugs", <i>Expert Opin Drug Metab Toxicol</i>, <b>6</b> (8): 919–938, <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1517%2F17425255.2010.487861">10.1517/17425255.2010.487861</a>, <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20446865">20446865</a>, <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:695545">695545</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opin+Drug+Metab+Toxicol&amp;rft.atitle=Oxazaphosphorines%3A+new+therapeutic+strategies+for+an+old+class+of+drugs&amp;rft.volume=6&amp;rft.issue=8&amp;rft.pages=919-938&amp;rft.date=2010&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A695545%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20446865&amp;rft_id=info%3Adoi%2F10.1517%2F17425255.2010.487861&amp;rft.aulast=Giraud&amp;rft.aufirst=B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHaubitzBohnenstengelBrunkhorstSchwab2002" class="citation journal cs1">Haubitz M, Bohnenstengel F, Brunkhorst R, Schwab M, Hofmann U, Busse D (April 2002). <a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1523-1755.2002.00279.x">"Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency"</a>. <i>Kidney International</i>. <b>61</b> (4): 1495–501. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1523-1755.2002.00279.x">10.1046/j.1523-1755.2002.00279.x</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11918757">11918757</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kidney+International&amp;rft.atitle=Cyclophosphamide+pharmacokinetics+and+dose+requirements+in+patients+with+renal+insufficiency&amp;rft.volume=61&amp;rft.issue=4&amp;rft.pages=1495-501&amp;rft.date=2002-04&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1523-1755.2002.00279.x&amp;rft_id=info%3Apmid%2F11918757&amp;rft.aulast=Haubitz&amp;rft.aufirst=M&amp;rft.au=Bohnenstengel%2C+F&amp;rft.au=Brunkhorst%2C+R&amp;rft.au=Schwab%2C+M&amp;rft.au=Hofmann%2C+U&amp;rft.au=Busse%2C+D&amp;rft_id=%2F%2Fdoi.org%2F10.1046%252Fj.1523-1755.2002.00279.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDonelliBartosekGuaitaniMartini1976" class="citation journal cs1">Donelli MG, Bartosek I, Guaitani A, Martini A, Colombo T, Pacciarini MA, Modica R (April 1976). "Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect". <i>Cancer Treatment Reports</i>. <b>60</b> (4): 395–401. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/1277213">1277213</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Treatment+Reports&amp;rft.atitle=Importance+of+pharmacokinetic+studies+on+cyclophosphamide+%28NSC-26271%29+in+understanding+its+cytotoxic+effect&amp;rft.volume=60&amp;rft.issue=4&amp;rft.pages=395-401&amp;rft.date=1976-04&amp;rft_id=info%3Apmid%2F1277213&amp;rft.aulast=Donelli&amp;rft.aufirst=MG&amp;rft.au=Bartosek%2C+I&amp;rft.au=Guaitani%2C+A&amp;rft.au=Martini%2C+A&amp;rft.au=Colombo%2C+T&amp;rft.au=Pacciarini%2C+MA&amp;rft.au=Modica%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKoseogluChiangChan1999" class="citation journal cs1">Koseoglu V, Chiang J, Chan KW (December 1999). <a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fsj.bmt.1702097">"Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide"</a>. <i>Bone Marrow Transplantation</i>. <b>24</b> (12): 1367–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fsj.bmt.1702097">10.1038/sj.bmt.1702097</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/10627651">10627651</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bone+Marrow+Transplantation&amp;rft.atitle=Acquired+pseudocholinesterase+deficiency+after+high-dose+cyclophosphamide&amp;rft.volume=24&amp;rft.issue=12&amp;rft.pages=1367-8&amp;rft.date=1999-12&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bmt.1702097&amp;rft_id=info%3Apmid%2F10627651&amp;rft.aulast=Koseoglu&amp;rft.aufirst=V&amp;rft.au=Chiang%2C+J&amp;rft.au=Chan%2C+KW&amp;rft_id=%2F%2Fdoi.org%2F10.1038%252Fsj.bmt.1702097&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFVigourouxVoltaire1995" class="citation journal cs1 cs1-prop-foreign-lang-source">Vigouroux D, Voltaire L (1995). "[Prolonged neuromuscular block induced by mivacurium in a patient treated with cyclophosphamide]" &#91;Prolonged neuromuscular block induced by mivacurium in a patient treated with cyclophosphamide&#93;. <i>Annales Françaises d'Anesthésie et de Réanimation</i> (in French). <b>14</b> (6): 508–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0750-7658%2805%2980493-9">10.1016/S0750-7658(05)80493-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8745976">8745976</a>. <a href="/wiki/Institut_de_l%27information_scientifique_et_technique" title="Institut de l&#39;information scientifique et technique">INIST</a>:<a rel="nofollow" class="external text" href="https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2947795">2947795</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annales+Fran%C3%A7aises+d%27Anesth%C3%A9sie+et+de+R%C3%A9animation&amp;rft.atitle=%5BProlonged+neuromuscular+block+induced+by+mivacurium+in+a+patient+treated+with+cyclophosphamide%5D&amp;rft.volume=14&amp;rft.issue=6&amp;rft.pages=508-10&amp;rft.date=1995&amp;rft_id=info%3Adoi%2F10.1016%2FS0750-7658%2805%2980493-9&amp;rft_id=info%3Apmid%2F8745976&amp;rft.aulast=Vigouroux&amp;rft.aufirst=D&amp;rft.au=Voltaire%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHallTilby1992" class="citation journal cs1">Hall AG, Tilby MJ (September 1992). "Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies". <i>Blood Reviews</i>. <b>6</b> (3): 163–73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0268-960X%2892%2990028-O">10.1016/0268-960X(92)90028-O</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/1422285">1422285</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood+Reviews&amp;rft.atitle=Mechanisms+of+action+of%2C+and+modes+of+resistance+to%2C+alkylating+agents+used+in+the+treatment+of+haematological+malignancies&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=163-73&amp;rft.date=1992-09&amp;rft_id=info%3Adoi%2F10.1016%2F0268-960X%2892%2990028-O&amp;rft_id=info%3Apmid%2F1422285&amp;rft.aulast=Hall&amp;rft.aufirst=AG&amp;rft.au=Tilby%2C+MJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid2996550-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2996550_47-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKohnSladek1985" class="citation journal cs1">Kohn FR, Sladek NE (October 1985). "Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines". <i>Biochemical Pharmacology</i>. <b>34</b> (19): 3465–71. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0006-2952%2885%2990719-1">10.1016/0006-2952(85)90719-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/2996550">2996550</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochemical+Pharmacology&amp;rft.atitle=Aldehyde+dehydrogenase+activity+as+the+basis+for+the+relative+insensitivity+of+murine+pluripotent+hematopoietic+stem+cells+to+oxazaphosphorines&amp;rft.volume=34&amp;rft.issue=19&amp;rft.pages=3465-71&amp;rft.date=1985-10&amp;rft_id=info%3Adoi%2F10.1016%2F0006-2952%2885%2990719-1&amp;rft_id=info%3Apmid%2F2996550&amp;rft.aulast=Kohn&amp;rft.aufirst=FR&amp;rft.au=Sladek%2C+NE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid1277209-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid1277209_48-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFriedmanWodinskyMyles1976" class="citation journal cs1">Friedman OM, Wodinsky I, Myles A (April 1976). "Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective". <i>Cancer Treatment Reports</i>. <b>60</b> (4): 337–46. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/1277209">1277209</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Treatment+Reports&amp;rft.atitle=Cyclophosphamide+%28NSC-26271%29-related+phosphoramide+mustards-+recent+advances+and+historical+perspective&amp;rft.volume=60&amp;rft.issue=4&amp;rft.pages=337-46&amp;rft.date=1976-04&amp;rft_id=info%3Apmid%2F1277209&amp;rft.aulast=Friedman&amp;rft.aufirst=OM&amp;rft.au=Wodinsky%2C+I&amp;rft.au=Myles%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSistiguViaudChaputBracci2011" class="citation journal cs1">Sistigu A, Viaud S, Chaput N, Bracci L, Proietti E, Zitvogel L (July 2011). "Immunomodulatory effects of cyclophosphamide and implementations for vaccine design". <i>Seminars in Immunopathology</i>. <b>33</b> (4): 369–83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00281-011-0245-0">10.1007/s00281-011-0245-0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21611872">21611872</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3360104">3360104</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Immunopathology&amp;rft.atitle=Immunomodulatory+effects+of+cyclophosphamide+and+implementations+for+vaccine+design&amp;rft.volume=33&amp;rft.issue=4&amp;rft.pages=369-83&amp;rft.date=2011-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3360104%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21611872&amp;rft_id=info%3Adoi%2F10.1007%2Fs00281-011-0245-0&amp;rft.aulast=Sistigu&amp;rft.aufirst=A&amp;rft.au=Viaud%2C+S&amp;rft.au=Chaput%2C+N&amp;rft.au=Bracci%2C+L&amp;rft.au=Proietti%2C+E&amp;rft.au=Zitvogel%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFriedmanSeligman1954" class="citation journal cs1">Friedman OM, Seligman AM (1954). "Preparation of N-Phosphorylated Derivatives of Bis-β-chloroethylamine1a". <i>Journal of the American Chemical Society</i>. <b>76</b> (3): 655–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1021%2Fja01632a006">10.1021/ja01632a006</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Chemical+Society&amp;rft.atitle=Preparation+of+N-Phosphorylated+Derivatives+of+Bis-%CE%B2-chloroethylamine1a&amp;rft.volume=76&amp;rft.issue=3&amp;rft.pages=655-8&amp;rft.date=1954&amp;rft_id=info%3Adoi%2F10.1021%2Fja01632a006&amp;rft.aulast=Friedman&amp;rft.aufirst=Orrie+M.&amp;rft.au=Seligman%2C+Arnold+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFColvin1999" class="citation journal cs1">Colvin OM (August 1999). "An overview of cyclophosphamide development and clinical applications". <i>Current Pharmaceutical Design</i>. <b>5</b> (8): 555–60. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/10469891">10469891</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Pharmaceutical+Design&amp;rft.atitle=An+overview+of+cyclophosphamide+development+and+clinical+applications&amp;rft.volume=5&amp;rft.issue=8&amp;rft.pages=555-60&amp;rft.date=1999-08&amp;rft_id=info%3Apmid%2F10469891&amp;rft.aulast=Colvin&amp;rft.aufirst=OM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><span><a rel="nofollow" class="external text" href="https://patents.google.com/patent/US3018302">U.S. Patent 3,018,302</a></span></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBrock1996" class="citation journal cs1">Brock N (August 1996). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C542%3A%3AAID-CNCR23%3E3.0.CO%3B2-Y">"The history of the oxazaphosphorine cytostatics"</a>. <i>Cancer</i>. <b>78</b> (3): 542–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C542%3A%3AAID-CNCR23%3E3.0.CO%3B2-Y">10.1002/(SICI)1097-0142(19960801)78:3&#60;542::AID-CNCR23&#62;3.0.CO;2-Y</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8697402">8697402</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer&amp;rft.atitle=The+history+of+the+oxazaphosphorine+cytostatics&amp;rft.volume=78&amp;rft.issue=3&amp;rft.pages=542-7&amp;rft.date=1996-08&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C542%3A%3AAID-CNCR23%3E3.0.CO%3B2-Y&amp;rft_id=info%3Apmid%2F8697402&amp;rft.aulast=Brock&amp;rft.aufirst=N&amp;rft_id=%2F%2Fdoi.org%2F10.1002%252F%2528SICI%25291097-0142%252819960801%252978%253A3%253C542%253A%253AAID-CNCR23%253E3.0.CO%253B2-Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWilmanns1958" class="citation book cs1 cs1-prop-foreign-lang-source">Wilmanns, Hilmar (1958). <i>Chemotherapie maligner Tumoren</i> &#91;<i>Chemotherapy of malignant tumors</i>&#93;. Asta-Forschung und Therapie (in German). <a href="/wiki/OCLC_(identifier)" class="mw-redirect" title="OCLC (identifier)">OCLC</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/oclc/73296245">73296245</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Chemotherapie+maligner+Tumoren&amp;rft.series=Asta-Forschung+und+Therapie&amp;rft.date=1958&amp;rft_id=info%3Aoclcnum%2F73296245&amp;rft.aulast=Wilmanns&amp;rft.aufirst=Hilmar&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span><sup class="noprint Inline-Template" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (May 2014)">page&#160;needed</span></a></i>&#93;</sup></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGrossWulf1959" class="citation journal cs1 cs1-prop-foreign-lang-source">Gross R, Wulf G (1959). "Klinische und experimentelle Erfahrungen mit zyk lischen und nichtzyklischen Phosphamidestern des N-Losl in der Chemotherapie von Tumoren" &#91;Clinical and experimental experiences with metallic cyclical and non-cyclical Phosphamidestern the N-losl in the chemotherapy of tumors&#93;. <i>Strahlentherapie</i> (in German). <b>41</b>: 361–7.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Strahlentherapie&amp;rft.atitle=Klinische+und+experimentelle+Erfahrungen+mit+zyk+lischen+und+nichtzyklischen+Phosphamidestern+des+N-Losl+in+der+Chemotherapie+von+Tumoren&amp;rft.volume=41&amp;rft.pages=361-7&amp;rft.date=1959&amp;rft.aulast=Gross&amp;rft.aufirst=R&amp;rft.au=Wulf%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBrock1989" class="citation journal cs1">Brock N (January 1989). <a rel="nofollow" class="external text" href="http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=2491747">"Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture"</a>. <i>Cancer Research</i>. <b>49</b> (1): 1–7. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/2491747">2491747</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Oxazaphosphorine+cytostatics%3A+past-present-future.+Seventh+Cain+Memorial+Award+lecture&amp;rft.volume=49&amp;rft.issue=1&amp;rft.pages=1-7&amp;rft.date=1989-01&amp;rft_id=info%3Apmid%2F2491747&amp;rft.aulast=Brock&amp;rft.aufirst=N&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D2491747&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-ISMP_list_do_not_abbreviate-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-ISMP_list_do_not_abbreviate_57-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFInstitute_for_Safe_Medication_Practices" class="citation cs2">Institute for Safe Medication Practices, <a rel="nofollow" class="external text" href="http://www.ismp.org/tools/errorproneabbreviations.pdf"><i>ISMP's List of Error-Prone Abbreviations, Symbols, and Dose Designations</i></a> <span class="cs1-format">(PDF)</span>, <a rel="nofollow" class="external text" href="https://web.archive.org/web/20111027133115/http://www.ismp.org/tools/errorproneabbreviations.pdf">archived</a> <span class="cs1-format">(PDF)</span> from the original on 2011-10-27.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=ISMP%27s+List+of+Error-Prone+Abbreviations%2C+Symbols%2C+and+Dose+Designations&amp;rft.au=Institute+for+Safe+Medication+Practices&amp;rft_id=http%3A%2F%2Fwww.ismp.org%2Ftools%2Ferrorproneabbreviations.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFZuluagaSalazarRodriguezZapata2006" class="citation journal cs1">Zuluaga AF, Salazar BE, Rodriguez CA, Zapata AX, Agudelo M, Vesga O (March 2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1434751">"Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases"</a>. <i>BMC Infectious Diseases</i>. <b>6</b> (1): 55. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2F1471-2334-6-55">10.1186/1471-2334-6-55</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1434751">1434751</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16545113">16545113</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Infectious+Diseases&amp;rft.atitle=Neutropenia+induced+in+outbred+mice+by+a+simplified+low-dose+cyclophosphamide+regimen%3A+characterization+and+applicability+to+diverse+experimental+models+of+infectious+diseases&amp;rft.volume=6&amp;rft.issue=1&amp;rft.pages=55&amp;rft.date=2006-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1434751%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F16545113&amp;rft_id=info%3Adoi%2F10.1186%2F1471-2334-6-55&amp;rft.aulast=Zuluaga&amp;rft.aufirst=AF&amp;rft.au=Salazar%2C+BE&amp;rft.au=Rodriguez%2C+CA&amp;rft.au=Zapata%2C+AX&amp;rft.au=Agudelo%2C+M&amp;rft.au=Vesga%2C+O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1434751&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.epa.gov/biotech_rule/pubs/submiss.htm">"Archived copy"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150621202223/http://www.epa.gov/biotech_rule/pubs/submiss.htm">Archived</a> from the original on 2015-06-21<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-07-01</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.epa.gov%2Fbiotech_rule%2Fpubs%2Fsubmiss.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_web" title="Template:Cite web">cite web</a>}}</code>:  CS1 maint: archived copy as title (<a href="/wiki/Category:CS1_maint:_archived_copy_as_title" title="Category:CS1 maint: archived copy as title">link</a>)</span></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHuyanLinGaoChen2011" class="citation journal cs1">Huyan XH, Lin YP, Gao T, Chen RY, Fan YM (September 2011). <a rel="nofollow" class="external text" href="https://zenodo.org/record/895552">"Immunosuppressive effect of cyclophosphamide on white blood cells and lymphocyte subpopulations from peripheral blood of Balb/c mice"</a>. <i>International Immunopharmacology</i>. <b>11</b> (9): 1293–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.intimp.2011.04.011">10.1016/j.intimp.2011.04.011</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21530682">21530682</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Immunopharmacology&amp;rft.atitle=Immunosuppressive+effect+of+cyclophosphamide+on+white+blood+cells+and+lymphocyte+subpopulations+from+peripheral+blood+of+Balb%2Fc+mice&amp;rft.volume=11&amp;rft.issue=9&amp;rft.pages=1293-7&amp;rft.date=2011-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.intimp.2011.04.011&amp;rft_id=info%3Apmid%2F21530682&amp;rft.aulast=Huyan&amp;rft.aufirst=XH&amp;rft.au=Lin%2C+YP&amp;rft.au=Gao%2C+T&amp;rft.au=Chen%2C+RY&amp;rft.au=Fan%2C+YM&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F895552&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></span>
</li>
</ol></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cyclophosphamide&amp;action=edit&amp;section=18" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://druginfo.nlm.nih.gov/drugportal/name/Cyclophosphamide+(anhydrous)">"Cyclophosphamide"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Drug+Information+Portal&amp;rft.atitle=Cyclophosphamide&amp;rft_id=https%3A%2F%2Fdruginfo.nlm.nih.gov%2Fdrugportal%2Fname%2FCyclophosphamide%2B%28anhydrous%29&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACyclophosphamide" class="Z3988"></span></li>
<li><span><a rel="nofollow" class="external text" href="https://patents.google.com/patent/US3018302">U.S. Patent 3,018,302</a></span> Novel cyclic phosphoric acid ester amides, and the production thereof. (patent for cyclophosphamide).</li></ul>
<div class="navbox-styles nomobile"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div role="navigation" class="navbox" aria-labelledby="Intracellular_chemotherapeutic_agents_/_antineoplastic_agents_(L01)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Chemotherapeutic_agents" title="Template:Chemotherapeutic agents"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Chemotherapeutic_agents" class="mw-redirect" title="Template talk:Chemotherapeutic agents"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Chemotherapeutic_agents&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Intracellular_chemotherapeutic_agents_/_antineoplastic_agents_(L01)" style="font-size:114%;margin:0 4em">Intracellular <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapeutic agents</a>&#160;/ <a href="/wiki/Antineoplastic" class="mw-redirect" title="Antineoplastic">antineoplastic agents</a> (<a href="/wiki/ATC_code_L01" title="ATC code L01">L01</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Spindle_poison" title="Spindle poison">SPs</a>/<a href="/wiki/Mitotic_inhibitor" title="Mitotic inhibitor">MIs</a><br />(<a href="/wiki/M_phase" class="mw-redirect" title="M phase">M phase</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Block <a href="/wiki/Microtubule" title="Microtubule">microtubule</a> assembly</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Catharanthus#Vinca_alkaloids" title="Catharanthus">Vinca alkaloids</a></i> (<a href="/wiki/Vinblastine" title="Vinblastine">Vinblastine</a><sup>#</sup></li>
<li><a href="/wiki/Vincristine" title="Vincristine">Vincristine</a><sup>#</sup></li>
<li><a href="/wiki/Vindesine" title="Vindesine">Vindesine</a></li>
<li><a href="/wiki/Vinflunine" title="Vinflunine">Vinflunine</a><sup>§</sup></li>
<li><a href="/wiki/Vinorelbine" title="Vinorelbine">Vinorelbine</a><sup>#</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Block microtubule disassembly</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Taxane" title="Taxane">Taxanes</a></i> (<a href="/wiki/Cabazitaxel" title="Cabazitaxel">Cabazitaxel</a></li>
<li><a href="/wiki/Docetaxel" title="Docetaxel">Docetaxel</a><sup>#</sup></li>
<li><a href="/wiki/Larotaxel" title="Larotaxel">Larotaxel</a></li>
<li><a href="/wiki/Ortataxel" title="Ortataxel">Ortataxel</a><sup>†</sup></li>
<li><a href="/wiki/Paclitaxel" title="Paclitaxel">Paclitaxel</a><sup>#</sup></li>
<li><a href="/wiki/Tesetaxel" title="Tesetaxel">Tesetaxel</a>)</li>
<li><i><a href="/wiki/Epothilone" title="Epothilone">Epothilones</a></i> (<a href="/wiki/Ixabepilone" title="Ixabepilone">Ixabepilone</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/DNA_replication" title="DNA replication">DNA replication</a><br />inhibitor</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">DNA precursors/<br /><a href="/wiki/Antimetabolite" title="Antimetabolite">antimetabolites</a><br />(<a href="/wiki/S_phase" title="S phase">S phase</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Antifolate" title="Antifolate">Folic acid</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Dihydrofolate_reductase_inhibitor" title="Dihydrofolate reductase inhibitor">Dihydrofolate reductase inhibitor</a></i> (<a href="/wiki/Aminopterin" title="Aminopterin">Aminopterin</a></li>
<li><a href="/wiki/Methotrexate" title="Methotrexate">Methotrexate</a><sup>#</sup></li>
<li><a href="/wiki/Pemetrexed" title="Pemetrexed">Pemetrexed</a></li>
<li><a href="/wiki/Pralatrexate" title="Pralatrexate">Pralatrexate</a>)</li>
<li><i><a href="/wiki/Thymidylate_synthase_inhibitor" title="Thymidylate synthase inhibitor">Thymidylate synthase inhibitor</a></i> (<a href="/wiki/Pemetrexed" title="Pemetrexed">Pemetrexed</a></li>
<li><a href="/wiki/Raltitrexed" title="Raltitrexed">Raltitrexed</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Purine_analogue" title="Purine analogue">Purine</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Adenosine_deaminase_inhibitor" class="mw-redirect" title="Adenosine deaminase inhibitor">Adenosine deaminase inhibitor</a></i> (<a href="/wiki/Pentostatin" title="Pentostatin">Pentostatin</a>)</li></ul>
<ul><li><i><a href="/wiki/Halogenation" title="Halogenation">Halogenated</a>/<a href="/wiki/Ribonucleotide_reductase_inhibitor" title="Ribonucleotide reductase inhibitor">ribonucleotide reductase inhibitors</a></i> (<a href="/wiki/Cladribine" title="Cladribine">Cladribine</a></li>
<li><a href="/wiki/Clofarabine" title="Clofarabine">Clofarabine</a></li>
<li><a href="/wiki/Fludarabine" title="Fludarabine">Fludarabine</a>)</li>
<li><a href="/wiki/Nelarabine" title="Nelarabine">Nelarabine</a></li></ul>
<ul><li><i><a href="/wiki/Thiopurine" title="Thiopurine">Thiopurine</a></i> (<a href="/wiki/Mercaptopurine" title="Mercaptopurine">Mercaptopurine</a><sup>#</sup></li>
<li><a href="/wiki/Tioguanine" title="Tioguanine">Tioguanine</a><sup>#</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Pyrimidine_analogue" title="Pyrimidine analogue">Pyrimidine</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Thymidylate_synthase_inhibitor" title="Thymidylate synthase inhibitor">Thymidylate synthase inhibitor</a></i> (<a href="/wiki/Capecitabine" title="Capecitabine">Capecitabine</a><sup>#</sup></li>
<li><a href="/wiki/Carmofur" title="Carmofur">Carmofur</a></li>
<li><a href="/wiki/Doxifluridine" title="Doxifluridine">Doxifluridine</a></li>
<li><a href="/wiki/Floxuridine" title="Floxuridine">Floxuridine</a></li>
<li><a href="/wiki/Fluorouracil" title="Fluorouracil">Fluorouracil</a><sup>#</sup></li>
<li><a href="/wiki/Tegafur" title="Tegafur">Tegafur</a> (<a href="/wiki/Tegafur/gimeracil/oteracil" title="Tegafur/gimeracil/oteracil">+gimeracil/oteracil</a>))</li></ul>
<ul><li><i><a href="/wiki/DNA_polymerase_inhibitor" class="mw-redirect" title="DNA polymerase inhibitor">DNA polymerase inhibitor</a></i> (<a href="/wiki/Cytarabine" title="Cytarabine">Cytarabine</a><sup>#</sup>)</li></ul>
<ul><li><i><a href="/wiki/Ribonucleotide_reductase_inhibitor" title="Ribonucleotide reductase inhibitor">Ribonucleotide reductase inhibitor</a></i> (<a href="/wiki/Gemcitabine" title="Gemcitabine">Gemcitabine</a><sup>#</sup>)</li></ul>
<ul><li><i><a href="/wiki/Hypomethylating_agent" title="Hypomethylating agent">Hypomethylating agent</a></i> (<a href="/wiki/Azacitidine" title="Azacitidine">Azacitidine</a></li>
<li><a href="/wiki/Decitabine" title="Decitabine">Decitabine</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Deoxyribonucleotide" title="Deoxyribonucleotide">Deoxyribonucleotide</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Ribonucleotide_reductase_inhibitor" title="Ribonucleotide reductase inhibitor">Ribonucleotide reductase inhibitor</a></i> (<a href="/wiki/Hydroxycarbamide" title="Hydroxycarbamide">Hydroxycarbamide</a><sup>#</sup>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Topoisomerase_inhibitor" title="Topoisomerase inhibitor">Topoisomerase inhibitors</a><br />(<a href="/wiki/S_phase" title="S phase">S phase</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_I_topoisomerase#Inhibition" title="Type I topoisomerase">I</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Camptotheca" title="Camptotheca">Camptotheca</a></i> (<a href="/wiki/Belotecan" title="Belotecan">Belotecan</a></li>
<li><a href="/wiki/Camptothecin" title="Camptothecin">Camptothecin</a></li>
<li><a href="/w/index.php?title=Cositecan&amp;action=edit&amp;redlink=1" class="new" title="Cositecan (page does not exist)">Cositecan</a><sup>†</sup></li>
<li><a href="/wiki/Etirinotecan_pegol" title="Etirinotecan pegol">Etirinotecan pegol</a><sup>†</sup></li>
<li><a href="/wiki/Exatecan" title="Exatecan">Exatecan</a></li>
<li><a href="/w/index.php?title=Gimatecan&amp;action=edit&amp;redlink=1" class="new" title="Gimatecan (page does not exist)">Gimatecan</a></li>
<li><a href="/wiki/Irinotecan" title="Irinotecan">Irinotecan</a><sup>#</sup></li>
<li><a href="/wiki/Lurtotecan" title="Lurtotecan">Lurtotecan</a><sup>‡</sup></li>
<li><a href="/wiki/Rubitecan" title="Rubitecan">Rubitecan</a><sup>‡</sup></li>
<li><a href="/w/index.php?title=Silatecan&amp;action=edit&amp;redlink=1" class="new" title="Silatecan (page does not exist)">Silatecan</a><sup>§</sup></li>
<li><a href="/wiki/Topotecan" title="Topotecan">Topotecan</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_II_topoisomerase#Inhibition" title="Type II topoisomerase">II</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Podophyllum_peltatum" class="mw-redirect" title="Podophyllum peltatum">Podophyllum</a></i> (<a href="/wiki/Etoposide" title="Etoposide">Etoposide</a><sup>#</sup></li>
<li><a href="/wiki/Teniposide" title="Teniposide">Teniposide</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Type_II_topoisomerase#Inhibition" title="Type II topoisomerase">II</a>+<a href="/wiki/Intercalation_(biochemistry)" title="Intercalation (biochemistry)">Intercalation</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Anthracycline" title="Anthracycline">Anthracyclines</a></i> (<a href="/wiki/Aclarubicin" title="Aclarubicin">Aclarubicin</a></li>
<li><a href="/wiki/Amrubicin" title="Amrubicin">Amrubicin</a><sup>†</sup></li>
<li><a href="/wiki/Daunorubicin" title="Daunorubicin">Daunorubicin</a><sup>#</sup></li>
<li><a href="/wiki/Doxorubicin" title="Doxorubicin">Doxorubicin</a><sup>#</sup></li>
<li><a href="/wiki/Epirubicin" title="Epirubicin">Epirubicin</a></li>
<li><a href="/wiki/Idarubicin" title="Idarubicin">Idarubicin</a></li>
<li><a href="/wiki/Pirarubicin" title="Pirarubicin">Pirarubicin</a></li>
<li><a href="/wiki/Valrubicin" title="Valrubicin">Valrubicin</a></li>
<li><a href="/wiki/Zorubicin" title="Zorubicin">Zorubicin</a>)</li>
<li><i><a href="/wiki/Anthraquinone" title="Anthraquinone">Anthracenediones</a></i> (<a href="/wiki/Mitoxantrone" title="Mitoxantrone">Mitoxantrone</a></li>
<li><a href="/wiki/Losoxantrone" title="Losoxantrone">Losoxantrone</a></li>
<li><a href="/wiki/Pixantrone" title="Pixantrone">Pixantrone</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Crosslinking_of_DNA" title="Crosslinking of DNA">Crosslinking of DNA</a><br />(<a href="/wiki/Cell-cycle_nonspecific_antineoplastic_agents" title="Cell-cycle nonspecific antineoplastic agents">CCNS</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Alkylating_antineoplastic_agent" title="Alkylating antineoplastic agent">Alkylating</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Nitrogen_mustard" title="Nitrogen mustard">Nitrogen mustards</a>:</i> <a href="/wiki/Bendamustine" title="Bendamustine">Bendamustine</a><sup>#</sup></li>
<li><a href="/wiki/Chlormethine" title="Chlormethine">Chlormethine</a></li>
<li><a class="mw-selflink selflink">Cyclophosphamide</a><sup>#</sup> (<a href="/wiki/Ifosfamide" title="Ifosfamide">Ifosfamide</a><sup>#</sup></li>
<li><a href="/wiki/Trofosfamide" title="Trofosfamide">Trofosfamide</a>)</li>
<li><a href="/wiki/Chlorambucil" title="Chlorambucil">Chlorambucil</a><sup>#</sup></li>
<li><a href="/wiki/Melphalan" title="Melphalan">Melphalan</a> (<a href="/wiki/Melphalan_flufenamide" title="Melphalan flufenamide">Melphalan flufenamide</a>)</li>
<li><a href="/wiki/Prednimustine" title="Prednimustine">Prednimustine</a></li>
<li><a href="/wiki/Uramustine" title="Uramustine">Uramustine</a></li></ul>
<ul><li><i><a href="/wiki/Nitrosourea" title="Nitrosourea">Nitrosoureas</a>:</i> <a href="/wiki/Carmustine" title="Carmustine">Carmustine</a></li>
<li><a href="/wiki/Fotemustine" title="Fotemustine">Fotemustine</a></li>
<li><a href="/wiki/Lomustine" title="Lomustine">Lomustine</a> (<a href="/wiki/Semustine" title="Semustine">Semustine</a>)</li>
<li><a href="/wiki/Nimustine" title="Nimustine">Nimustine</a></li>
<li><a href="/wiki/Ranimustine" title="Ranimustine">Ranimustine</a></li>
<li><a href="/wiki/Streptozotocin" title="Streptozotocin">Streptozocin</a></li></ul>
<ul><li><i><a href="/wiki/Alkyl_sulfonate" title="Alkyl sulfonate">Alkyl sulfonates</a>:</i> <a href="/wiki/Busulfan" title="Busulfan">Busulfan</a> (<a href="/wiki/Mannosulfan" title="Mannosulfan">Mannosulfan</a></li>
<li><a href="/wiki/Treosulfan" title="Treosulfan">Treosulfan</a>)</li></ul>
<ul><li><i><a href="/wiki/Aziridine" title="Aziridine">Aziridines</a>:</i> <a href="/wiki/Carboquone" title="Carboquone">Carboquone</a></li>
<li><a href="/wiki/Thiotepa" title="Thiotepa">Thiotepa</a></li>
<li><a href="/wiki/Triaziquone" title="Triaziquone">Triaziquone</a></li>
<li><a href="/wiki/Triethylenemelamine" title="Triethylenemelamine">Triethylenemelamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Platinum-based_antineoplastic" title="Platinum-based antineoplastic">Platinum-based</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Carboplatin" title="Carboplatin">Carboplatin</a><sup>#</sup></li>
<li><a href="/wiki/Cisplatin" title="Cisplatin">Cisplatin</a><sup>#</sup></li>
<li><a href="/wiki/Dicycloplatin" title="Dicycloplatin">Dicycloplatin</a></li>
<li><a href="/wiki/Nedaplatin" title="Nedaplatin">Nedaplatin</a></li>
<li><a href="/wiki/Oxaliplatin" title="Oxaliplatin">Oxaliplatin</a><sup>#</sup></li>
<li><a href="/wiki/Satraplatin" title="Satraplatin">Satraplatin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Alkylating_antineoplastic_agent#Nonclassical" title="Alkylating antineoplastic agent">Nonclassical</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Altretamine" title="Altretamine">Altretamine</a></li>
<li><i><a href="/wiki/Hydrazine" title="Hydrazine">Hydrazines</a></i> (<a href="/wiki/Procarbazine" title="Procarbazine">Procarbazine</a><sup>#</sup>)</li>
<li><a href="/wiki/Mitobronitol" title="Mitobronitol">Mitobronitol</a></li>
<li><a href="/wiki/Pipobroman" title="Pipobroman">Pipobroman</a></li>
<li><i><a href="/wiki/Triazene" title="Triazene">Triazenes</a></i> (<a href="/wiki/Dacarbazine" title="Dacarbazine">Dacarbazine</a><sup>#</sup></li>
<li><a href="/wiki/Mitozolomide" title="Mitozolomide">Mitozolomide</a><sup>§</sup></li>
<li><a href="/wiki/Temozolomide" title="Temozolomide">Temozolomide</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Intercalation_(biochemistry)" title="Intercalation (biochemistry)">Intercalation</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Streptomyces" title="Streptomyces">Streptomyces</a> (<a href="/wiki/Dactinomycin" title="Dactinomycin">Dactinomycin</a><sup>#</sup></li>
<li><a href="/wiki/Bleomycin" title="Bleomycin">Bleomycin</a><sup>#</sup></li>
<li><a href="/wiki/Mitomycins" title="Mitomycins">Mitomycins</a></li>
<li><a href="/wiki/Plicamycin" title="Plicamycin">Plicamycin</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Photosensitizer" title="Photosensitizer">Photosensitizers</a>/<a href="/wiki/Photodynamic_therapy" title="Photodynamic therapy">PDT</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Aminolevulinic_acid" title="Aminolevulinic acid">Aminolevulinic acid</a></li>
<li><a href="/wiki/Efaproxiral" title="Efaproxiral">Efaproxiral</a></li>
<li><a href="/wiki/Methyl_aminolevulinate" title="Methyl aminolevulinate">Methyl aminolevulinate</a></li>
<li><a href="/wiki/Padeliporfin" title="Padeliporfin">Padeliporfin</a></li>
<li><i><a href="/wiki/Porphyrin" title="Porphyrin">Porphyrin derivatives</a></i> (<a href="/wiki/Porfimer_sodium" title="Porfimer sodium">Porfimer sodium</a></li>
<li><a href="/wiki/Talaporfin" title="Talaporfin">Talaporfin</a></li>
<li><a href="/wiki/Temoporfin" title="Temoporfin">Temoporfin</a></li>
<li><a href="/wiki/Verteporfin" title="Verteporfin">Verteporfin</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">Enzyme inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Farnesyltransferase_inhibitor" title="Farnesyltransferase inhibitor">FI</a></i> (<a href="/wiki/Tipifarnib" title="Tipifarnib">Tipifarnib</a><sup>§</sup>)</li>
<li><i><a href="/wiki/Cyclin-dependent_kinase" title="Cyclin-dependent kinase">CDK</a> <a href="/wiki/Protein_kinase_inhibitor" title="Protein kinase inhibitor">inhibitors</a></i> (<a href="/wiki/Abemaciclib" title="Abemaciclib">Abemaciclib</a></li>
<li><a href="/wiki/Alvocidib" title="Alvocidib">Alvocidib</a><sup>†</sup></li>
<li><a href="/wiki/Palbociclib" title="Palbociclib">Palbociclib</a></li>
<li><a href="/wiki/Ribociclib" title="Ribociclib">Ribociclib</a></li>
<li><a href="/wiki/Seliciclib" title="Seliciclib">Seliciclib</a><sup>†</sup>)</li>
<li><i><a href="/wiki/Proteasome_inhibitor" title="Proteasome inhibitor">PrI</a></i>
<ul><li><a href="/wiki/Bortezomib" title="Bortezomib">Bortezomib</a></li>
<li><a href="/wiki/Carfilzomib" title="Carfilzomib">Carfilzomib</a></li>
<li><a href="/wiki/Oprozomib" title="Oprozomib">Oprozomib</a></li>
<li><a href="/wiki/Ixazomib" title="Ixazomib">Ixazomib</a></li></ul></li>
<li><i><a href="/wiki/Phosphodiesterase_inhibitor" title="Phosphodiesterase inhibitor">PhI</a></i> (<a href="/wiki/Anagrelide" title="Anagrelide">Anagrelide</a>)</li>
<li><i><a href="/wiki/IMP_dehydrogenase" class="mw-redirect" title="IMP dehydrogenase">IMPDI</a></i> (<a href="/wiki/Tiazofurin" title="Tiazofurin">Tiazofurin</a><sup>§</sup>)</li>
<li><i><a href="/wiki/Lipoxygenase_inhibitor" class="mw-redirect" title="Lipoxygenase inhibitor">LI</a></i> (<a href="/wiki/Masoprocol" title="Masoprocol">Masoprocol</a>)</li>
<li><i><a href="/wiki/PARP_inhibitor" title="PARP inhibitor">PARP inhibitor</a></i> (<a href="/wiki/Niraparib" title="Niraparib">Niraparib</a></li>
<li><a href="/wiki/Olaparib" title="Olaparib">Olaparib</a></li>
<li><a href="/wiki/Rucaparib" title="Rucaparib">Rucaparib</a>)</li>
<li><i><a href="/wiki/Histone_deacetylase_inhibitor" title="Histone deacetylase inhibitor">HDAC</a></i> (<a href="/wiki/Belinostat" title="Belinostat">Belinostat</a></li>
<li><a href="/wiki/Entinostat" title="Entinostat">Entinostat</a></li>
<li><a href="/wiki/Panobinostat" title="Panobinostat">Panobinostat</a></li>
<li><a href="/wiki/Romidepsin" title="Romidepsin">Romidepsin</a></li>
<li><a href="/wiki/Vorinostat" title="Vorinostat">Vorinostat</a>)</li>
<li><i><a href="/wiki/Phosphoinositide_3-kinase_inhibitor" title="Phosphoinositide 3-kinase inhibitor">PIKI</a> (Pi3K)</i> (<a href="/wiki/Alpelisib" title="Alpelisib">Alpelisib</a></li>
<li><a href="/wiki/Copanlisib" title="Copanlisib">Copanlisib</a></li>
<li><a href="/wiki/Duvelisib" title="Duvelisib">Duvelisib</a></li>
<li><a href="/wiki/Idelalisib" title="Idelalisib">Idelalisib</a></li>
<li><a href="/wiki/Umbralisib" title="Umbralisib">Umbralisib</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Receptor_antagonist" title="Receptor antagonist">Receptor antagonists</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Endothelin_receptor_antagonist" title="Endothelin receptor antagonist">ERA</a></i> (<a href="/wiki/Atrasentan" title="Atrasentan">Atrasentan</a>)</li>
<li><i><a href="/wiki/Retinoid_X_receptor" title="Retinoid X receptor">Retinoid X receptor</a></i> (<a href="/wiki/Bexarotene" title="Bexarotene">Bexarotene</a>)</li>
<li><i><a href="/wiki/Sex_steroid" class="mw-redirect" title="Sex steroid">Sex steroid</a></i> (<a href="/wiki/Testolactone" title="Testolactone">Testolactone</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other/ungrouped</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Amsacrine" title="Amsacrine">Amsacrine</a></li>
<li><a href="/wiki/Arsenic_trioxide" title="Arsenic trioxide">Arsenic trioxide</a></li>
<li><i><a href="/wiki/Asparagine" title="Asparagine">Asparagine depleters</a></i> (<a href="/wiki/Asparaginase" title="Asparaginase">Asparaginase</a><sup>#</sup>/<a href="/wiki/Pegaspargase" title="Pegaspargase">Pegaspargase</a>)</li>
<li><a href="/wiki/Belzutifan" title="Belzutifan">Belzutifan</a></li>
<li><a href="/wiki/Celecoxib" title="Celecoxib">Celecoxib</a></li>
<li><a href="/wiki/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li><a href="/wiki/Elesclomol" title="Elesclomol">Elesclomol</a><sup>§</sup></li>
<li><a href="/wiki/Elsamitrucin" title="Elsamitrucin">Elsamitrucin</a></li>
<li><a href="/wiki/Eribulin" title="Eribulin">Eribulin</a></li>
<li><a href="/wiki/Estramustine_phosphate" title="Estramustine phosphate">Estramustine phosphate</a></li>
<li><a href="/wiki/Etoglucid" title="Etoglucid">Etoglucid</a></li>
<li><a href="/wiki/Lonidamine" title="Lonidamine">Lonidamine</a></li>
<li><a href="/wiki/Lucanthone" title="Lucanthone">Lucanthone</a></li>
<li><a href="/wiki/Mitoguazone" title="Mitoguazone">Mitoguazone</a></li>
<li><a href="/wiki/Mitotane" title="Mitotane">Mitotane</a></li>
<li><a href="/wiki/Oblimersen" title="Oblimersen">Oblimersen</a><sup>†</sup></li>
<li><a href="/wiki/Omacetaxine_mepesuccinate" title="Omacetaxine mepesuccinate">Omacetaxine mepesuccinate</a></li>
<li><a href="/wiki/Trabectedin" title="Trabectedin">Trabectedin</a></li>
<li><i><a href="/wiki/Retinoid" title="Retinoid">Retinoids</a></i> (<a href="/wiki/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><a href="/wiki/Bexarotene" title="Bexarotene">Bexarotene</a></li>
<li><a href="/wiki/Tretinoin" title="Tretinoin">Tretinoin</a><sup>#</sup>)</li>
<li><a href="/wiki/Veliparib" title="Veliparib">Veliparib</a></li>
<li><a href="/wiki/Venetoclax" title="Venetoclax">Venetoclax</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div class="navbox-styles nomobile"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"/></div><div role="navigation" class="navbox" aria-labelledby="Xenobiotic-sensing_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Xenobiotic-sensing_receptor_modulators" title="Template:Xenobiotic-sensing receptor modulators"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Xenobiotic-sensing_receptor_modulators" title="Template talk:Xenobiotic-sensing receptor modulators"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Xenobiotic-sensing_receptor_modulators&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Xenobiotic-sensing_receptor_modulators" style="font-size:114%;margin:0 4em"><a href="/wiki/Xenobiotic-sensing_receptor" title="Xenobiotic-sensing receptor">Xenobiotic-sensing receptor</a> <a href="/wiki/Receptor_modulator" title="Receptor modulator">modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Constitutive_androstane_receptor" title="Constitutive androstane receptor"><abbr title="Constitutive androstane receptor">CAR</abbr></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i>Agonists:</i> <a href="/w/index.php?title=6,7-Dimethylesculetin&amp;action=edit&amp;redlink=1" class="new" title="6,7-Dimethylesculetin (page does not exist)">6,7-Dimethylesculetin</a></li>
<li><a href="/wiki/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li><a href="/wiki/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><a href="/w/index.php?title=Benfuracarb&amp;action=edit&amp;redlink=1" class="new" title="Benfuracarb (page does not exist)">Benfuracarb</a></li>
<li><a href="/wiki/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li><a href="/wiki/Carvedilol" title="Carvedilol">Carvedilol</a></li>
<li><a href="/wiki/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="/wiki/Chrysin" title="Chrysin">Chrysin</a></li>
<li><a href="/w/index.php?title=CITCO_(drug)&amp;action=edit&amp;redlink=1" class="new" title="CITCO (drug) (page does not exist)">CITCO</a></li>
<li><a href="/wiki/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a class="mw-selflink selflink">Cyclophosphamide</a></li>
<li><a href="/wiki/Cypermethrin" title="Cypermethrin">Cypermethrin</a></li>
<li><a href="/wiki/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (<a href="/wiki/Prasterone" title="Prasterone">prasterone</a>)</li>
<li><a href="/wiki/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li><a href="/wiki/Ellagic_acid" title="Ellagic acid">Ellagic acid</a></li>
<li><a href="/wiki/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li><a href="/wiki/Methoxychlor" title="Methoxychlor">Methoxychlor</a></li>
<li><a href="/wiki/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="/wiki/Nevirapine" title="Nevirapine">Nevirapine</a></li>
<li><a href="/wiki/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><a href="/w/index.php?title=Octicizer&amp;action=edit&amp;redlink=1" class="new" title="Octicizer (page does not exist)">Octicizer</a></li>
<li><a href="/wiki/Permethrin" title="Permethrin">Permethrin</a></li>
<li><a href="/wiki/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="/wiki/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li><a href="/wiki/5%CE%B2-Dihydroprogesterone" title="5β-Dihydroprogesterone">Pregnanedione (5β-dihydroprogesterone)</a></li>
<li><a href="/wiki/Reserpine" title="Reserpine">Reserpine</a></li>
<li><a href="/w/index.php?title=TCPOBOP&amp;action=edit&amp;redlink=1" class="new" title="TCPOBOP (page does not exist)">TCPOBOP</a></li>
<li><a href="/wiki/Telmisartan" title="Telmisartan">Telmisartan</a></li>
<li><a href="/wiki/Tolnaftate" title="Tolnaftate">Tolnaftate</a></li>
<li><a href="/wiki/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="/wiki/Valproic_acid" class="mw-redirect" title="Valproic acid">Valproic acid</a></li></ul>
<ul><li><i>Antagonists:</i> <a href="/w/index.php?title=3,17%CE%B2-Estradiol&amp;action=edit&amp;redlink=1" class="new" title="3,17β-Estradiol (page does not exist)">3,17β-Estradiol</a></li>
<li><a href="/w/index.php?title=5%CE%B1-Androstan-3%CE%B1-ol&amp;action=edit&amp;redlink=1" class="new" title="5α-Androstan-3α-ol (page does not exist)">3α-Androstanol</a></li>
<li><a href="/wiki/5%CE%B1-Androst-16-en-3%CE%B1-ol" class="mw-redirect" title="5α-Androst-16-en-3α-ol">3α-Androstenol</a></li>
<li><a href="/w/index.php?title=5%CE%B1-Androstan-3%CE%B2-ol&amp;action=edit&amp;redlink=1" class="new" title="5α-Androstan-3β-ol (page does not exist)">3β-Androstanol</a></li>
<li><a href="/w/index.php?title=5%CE%B1-Androstan-17-ol&amp;action=edit&amp;redlink=1" class="new" title="5α-Androstan-17-ol (page does not exist)">17-Androstanol</a></li>
<li><a href="/wiki/Allyl_isothiocyanate" title="Allyl isothiocyanate">AITC</a></li>
<li><a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">Ethinylestradiol</a></li>
<li><a href="/wiki/Meclizine" title="Meclizine">Meclizine</a></li>
<li><a href="/w/index.php?title=Nigramide_J&amp;action=edit&amp;redlink=1" class="new" title="Nigramide J (page does not exist)">Nigramide J</a></li>
<li><a href="/wiki/Okadaic_acid" title="Okadaic acid">Okadaic acid</a></li>
<li><a href="/wiki/PK-11195" title="PK-11195">PK-11195</a></li>
<li><a href="/w/index.php?title=S-07662&amp;action=edit&amp;redlink=1" class="new" title="S-07662 (page does not exist)">S-07662</a></li>
<li><a href="/w/index.php?title=T-0901317&amp;action=edit&amp;redlink=1" class="new" title="T-0901317 (page does not exist)">T-0901317</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Pregnane_X_receptor" title="Pregnane X receptor"><abbr title="Pregnane X receptor">PXR</abbr></a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i>Agonists:</i> <a href="/wiki/17%CE%B1-Hydroxypregnenolone" title="17α-Hydroxypregnenolone">17α-Hydroxypregnenolone</a></li>
<li><a href="/wiki/17%CE%B1-Hydroxyprogesterone" title="17α-Hydroxyprogesterone">17α-Hydroxyprogesterone</a></li>
<li><a href="/wiki/%CE%944-Androstenedione" class="mw-redirect" title="Δ4-Androstenedione">Δ<sup>4</sup>-Androstenedione</a></li>
<li><a href="/wiki/%CE%945-Androstenediol" class="mw-redirect" title="Δ5-Androstenediol">Δ<sup>5</sup>-Androstenediol</a></li>
<li><a href="/wiki/%CE%945-Androstenedione" class="mw-redirect" title="Δ5-Androstenedione">Δ<sup>5</sup>-Androstenedione</a></li>
<li><a href="/w/index.php?title=AA-861&amp;action=edit&amp;redlink=1" class="new" title="AA-861 (page does not exist)">AA-861</a></li>
<li><a href="/wiki/Allopregnanediol" title="Allopregnanediol">Allopregnanediol</a></li>
<li><a href="/wiki/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">Allopregnanedione (5α-dihydroprogesterone)</a></li>
<li><a href="/wiki/Allopregnanolone" title="Allopregnanolone">Allopregnanolone (brexanolone)</a></li>
<li><a href="/wiki/Alpha-Lipoic_acid" class="mw-redirect" title="Alpha-Lipoic acid">Alpha-Lipoic acid</a></li>
<li><a href="/wiki/Ambrisentan" title="Ambrisentan">Ambrisentan</a></li>
<li><a href="/wiki/AMI-193" class="mw-redirect" title="AMI-193">AMI-193</a></li>
<li><a href="/wiki/Amlodipine_besylate" class="mw-redirect" title="Amlodipine besylate">Amlodipine besylate</a></li>
<li><a href="/wiki/Antimycotic" class="mw-redirect" title="Antimycotic">Antimycotics</a></li>
<li><a href="/wiki/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><a href="/wiki/Aurothioglucose" title="Aurothioglucose">Aurothioglucose</a></li>
<li><a href="/wiki/Bile_acid" title="Bile acid">Bile acids</a></li>
<li><a href="/wiki/Bithionol" title="Bithionol">Bithionol</a></li>
<li><a href="/wiki/Bosentan" title="Bosentan">Bosentan</a></li>
<li><a href="/w/index.php?title=Bumecaine&amp;action=edit&amp;redlink=1" class="new" title="Bumecaine (page does not exist)">Bumecaine</a></li>
<li><a href="/wiki/Cafestol" title="Cafestol">Cafestol</a></li>
<li><a href="/wiki/Cephaloridine" title="Cephaloridine">Cephaloridine</a></li>
<li><a href="/wiki/Cephradine" class="mw-redirect" title="Cephradine">Cephradine</a></li>
<li><a href="/wiki/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="/wiki/Ciglitazone" title="Ciglitazone">Ciglitazone</a></li>
<li><a href="/wiki/Clindamycin" title="Clindamycin">Clindamycin</a></li>
<li><a href="/wiki/Clofenvinfos" class="mw-redirect" title="Clofenvinfos">Clofenvinfos</a></li>
<li><a href="/wiki/Chloroxine" title="Chloroxine">Chloroxine</a></li>
<li><a href="/wiki/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="/wiki/Colforsin" class="mw-redirect" title="Colforsin">Colforsin</a></li>
<li><a href="/wiki/Corticosterone" title="Corticosterone">Corticosterone</a></li>
<li><a class="mw-selflink selflink">Cyclophosphamide</a></li>
<li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li>
<li><a href="/wiki/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li><a href="/wiki/Dexamethasone" title="Dexamethasone">Dexamethasone</a></li>
<li><a href="/wiki/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (<a href="/wiki/Prasterone" title="Prasterone">prasterone</a>)</li>
<li><a href="/wiki/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA-S</a> (<a href="/wiki/Prasterone_sulfate" title="Prasterone sulfate">prasterone sulfate</a>)</li>
<li><a href="/wiki/Dibunate_sodium" class="mw-redirect" title="Dibunate sodium">Dibunate sodium</a></li>
<li><a href="/wiki/Diclazuril" title="Diclazuril">Diclazuril</a></li>
<li><a href="/wiki/Dicloxacillin" title="Dicloxacillin">Dicloxacillin</a></li>
<li><a href="/wiki/Dimercaprol" title="Dimercaprol">Dimercaprol</a></li>
<li><a href="/w/index.php?title=Dinaline&amp;action=edit&amp;redlink=1" class="new" title="Dinaline (page does not exist)">Dinaline</a></li>
<li><a href="/wiki/Docetaxel" title="Docetaxel">Docetaxel</a></li>
<li><a href="/wiki/Docusate_calcium" class="mw-redirect" title="Docusate calcium">Docusate calcium</a></li>
<li><a href="/wiki/Dodecylbenzenesulfonic_acid" class="mw-redirect" title="Dodecylbenzenesulfonic acid">Dodecylbenzenesulfonic acid</a></li>
<li><a href="/wiki/Dronabinol" title="Dronabinol">Dronabinol</a></li>
<li><a href="/wiki/Droxidopa" title="Droxidopa">Droxidopa</a></li>
<li><a href="/wiki/Eburnamonine" class="mw-redirect" title="Eburnamonine">Eburnamonine</a></li>
<li><a href="/wiki/Ecopipam" title="Ecopipam">Ecopipam</a></li>
<li><a href="/wiki/Enzacamene" title="Enzacamene">Enzacamene</a></li>
<li><a href="/wiki/Epothilone_B" class="mw-redirect" title="Epothilone B">Epothilone B</a></li>
<li><a href="/wiki/Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li><a href="/wiki/Famprofazone" title="Famprofazone">Famprofazone</a></li>
<li><a href="/w/index.php?title=Febantel&amp;action=edit&amp;redlink=1" class="new" title="Febantel (page does not exist)">Febantel</a></li>
<li><a href="/wiki/Felodipine" title="Felodipine">Felodipine</a></li>
<li><a href="/wiki/Fenbendazole" title="Fenbendazole">Fenbendazole</a></li>
<li><a href="/wiki/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="/wiki/Flucloxacillin" title="Flucloxacillin">Flucloxacillin</a></li>
<li><a href="/wiki/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li>
<li><a href="/wiki/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li><a href="/wiki/Guggulsterone" title="Guggulsterone">Guggulsterone</a></li>
<li><a href="/wiki/Haloprogin" title="Haloprogin">Haloprogin</a></li>
<li><a href="/wiki/Hetacillin_potassium" class="mw-redirect" title="Hetacillin potassium">Hetacillin potassium</a></li>
<li><a href="/wiki/Hyperforin" title="Hyperforin">Hyperforin</a></li>
<li><a href="/wiki/Hypericum_perforatum" title="Hypericum perforatum"><i>Hypericum perforatum</i> (St John's wort)</a></li>
<li><a href="/wiki/Indinavir_sulfate" class="mw-redirect" title="Indinavir sulfate">Indinavir sulfate</a></li>
<li><a href="/wiki/Lasalocid_sodium" class="mw-redirect" title="Lasalocid sodium">Lasalocid sodium</a></li>
<li><a href="/wiki/Levothyroxine" title="Levothyroxine">Levothyroxine</a></li>
<li><a href="/wiki/Linolenic_acid" title="Linolenic acid">Linolenic acid</a></li>
<li><a href="/w/index.php?title=LOE-908&amp;action=edit&amp;redlink=1" class="new" title="LOE-908 (page does not exist)">LOE-908</a></li>
<li><a href="/wiki/Loratadine" title="Loratadine">Loratadine</a></li>
<li><a href="/wiki/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li><a href="/wiki/Meclizine" title="Meclizine">Meclizine</a></li>
<li><a href="/wiki/Metacycline" title="Metacycline">Metacycline</a></li>
<li><a href="/wiki/Methylprednisolone" title="Methylprednisolone">Methylprednisolone</a></li>
<li><a href="/wiki/Metyrapone" title="Metyrapone">Metyrapone</a></li>
<li><a href="/wiki/Mevastatin" title="Mevastatin">Mevastatin</a></li>
<li><a href="/wiki/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="/wiki/Nafcillin" title="Nafcillin">Nafcillin</a></li>
<li><a href="/wiki/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><a href="/wiki/Nicotine" title="Nicotine">Nicotine</a></li>
<li><a href="/wiki/Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li><a href="/wiki/Nilvadipine" title="Nilvadipine">Nilvadipine</a></li>
<li><a href="/wiki/Nisoldipine" title="Nisoldipine">Nisoldipine</a></li>
<li><a href="/wiki/Norelgestromin" title="Norelgestromin">Norelgestromin</a></li>
<li><a href="/wiki/Omeprazole" title="Omeprazole">Omeprazole</a></li>
<li><a href="/wiki/Orlistat" title="Orlistat">Orlistat</a></li>
<li><a href="/wiki/Oxatomide" title="Oxatomide">Oxatomide</a></li>
<li><a href="/wiki/Paclitaxel" title="Paclitaxel">Paclitaxel</a></li>
<li><a href="/wiki/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="/wiki/Piperine" title="Piperine">Piperine</a></li>
<li><a href="/wiki/Plicamycin" title="Plicamycin">Plicamycin</a></li>
<li><a href="/wiki/Prednisolone" title="Prednisolone">Prednisolone</a></li>
<li><a href="/wiki/Pregnanediol" title="Pregnanediol">Pregnanediol</a></li>
<li><a href="/wiki/5%CE%B2-Dihydroprogesterone" title="5β-Dihydroprogesterone">Pregnanedione (5β-dihydroprogesterone)</a></li>
<li><a href="/wiki/Pregnanolone" title="Pregnanolone">Pregnanolone</a></li>
<li><a href="/wiki/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li><a href="/wiki/Pregnenolone_16%CE%B1-carbonitrile" title="Pregnenolone 16α-carbonitrile">Pregnenolone 16α-carbonitrile</a></li>
<li><a href="/wiki/Proadifen" title="Proadifen">Proadifen</a></li>
<li><a href="/wiki/Progesterone" title="Progesterone">Progesterone</a></li>
<li><a href="/wiki/Quingestrone" title="Quingestrone">Quingestrone</a></li>
<li><a href="/wiki/Reserpine" title="Reserpine">Reserpine</a></li>
<li><a href="/wiki/Reverse_triiodothyronine" title="Reverse triiodothyronine">Reverse triiodothyronine</a></li>
<li><a href="/wiki/Rifampicin" title="Rifampicin">Rifampicin</a></li>
<li><a href="/wiki/Rifaximin" title="Rifaximin">Rifaximin</a></li>
<li><a href="/wiki/Rimexolone" title="Rimexolone">Rimexolone</a></li>
<li><a href="/wiki/Riodipine" title="Riodipine">Riodipine</a></li>
<li><a href="/wiki/Ritonavir" title="Ritonavir">Ritonavir</a></li>
<li><a href="/wiki/Simvastatin" title="Simvastatin">Simvastatin</a></li>
<li><a href="/wiki/Sirolimus" title="Sirolimus">Sirolimus</a></li>
<li><a href="/wiki/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li><a href="/wiki/Spiroxatrine" title="Spiroxatrine">Spiroxatrine</a></li>
<li><a href="/w/index.php?title=SR-12813&amp;action=edit&amp;redlink=1" class="new" title="SR-12813 (page does not exist)">SR-12813</a></li>
<li><a href="/w/index.php?title=Suberoylanilide&amp;action=edit&amp;redlink=1" class="new" title="Suberoylanilide (page does not exist)">Suberoylanilide</a></li>
<li><a href="/wiki/Sulfisoxazole" class="mw-redirect" title="Sulfisoxazole">Sulfisoxazole</a></li>
<li><a href="/wiki/Suramin" title="Suramin">Suramin</a></li>
<li><a href="/wiki/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><a href="/w/index.php?title=Tenylidone&amp;action=edit&amp;redlink=1" class="new" title="Tenylidone (page does not exist)">Tenylidone</a></li>
<li><a href="/wiki/Terconazole" title="Terconazole">Terconazole</a></li>
<li><a href="/wiki/Testosterone_isocaproate" title="Testosterone isocaproate">Testosterone isocaproate</a></li>
<li><a href="/wiki/Tetracycline" title="Tetracycline">Tetracycline</a></li>
<li><a href="/wiki/Thiamylal_sodium" class="mw-redirect" title="Thiamylal sodium">Thiamylal sodium</a></li>
<li><a href="/wiki/Thiothixene" class="mw-redirect" title="Thiothixene">Thiothixene</a></li>
<li><a href="/wiki/Thonzonium_bromide" title="Thonzonium bromide">Thonzonium bromide</a></li>
<li><a href="/wiki/Tianeptine" title="Tianeptine">Tianeptine</a></li>
<li><a href="/wiki/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="/wiki/Troleandomycin" title="Troleandomycin">Troleandomycin</a></li>
<li><a href="/w/index.php?title=Tropanyl_3,5-dimethulbenzoate&amp;action=edit&amp;redlink=1" class="new" title="Tropanyl 3,5-dimethulbenzoate (page does not exist)">Tropanyl 3,5-dimethulbenzoate</a></li>
<li><a href="/wiki/Zafirlukast" title="Zafirlukast">Zafirlukast</a></li>
<li><a href="/wiki/Zeranol" title="Zeranol">Zeranol</a></li></ul>
<ul><li><i>Antagonists:</i> <a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="/wiki/Sesamin" title="Sesamin">Sesamin</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i><a href="/wiki/Template:Receptor_modulators" title="Template:Receptor modulators">Receptor/signaling modulators</a></i></dd></dl>
</div></td></tr></tbody></table></div>
<p><br />
</p>
<style data-mw-deduplicate="TemplateStyles:r1061077711">.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;justify-content:center;align-items:baseline}.mw-parser-output .portal-bar-bordered{padding:0 2em;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em auto 0}.mw-parser-output .portal-bar-unbordered{padding:0 1.7em;margin-left:0}.mw-parser-output .portal-bar-header{margin:0 1em 0 0.5em;padding:0.2em 0;flex:0 0 auto;min-height:24px;line-height:22px}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:baseline;flex:0 1 auto;padding:0.15em 0;column-gap:1em}.mw-parser-output .portal-bar-item{display:flex;align-items:baseline;margin:0.15em 0;min-height:24px;text-align:left}.mw-parser-output .portal-bar-logo{width:22px;line-height:22px;margin:0 0.2em;text-align:right}.mw-parser-output .portal-bar-link{margin:0 0.2em;text-align:left}@media screen and (max-width:768px){.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;flex-flow:column wrap}.mw-parser-output .portal-bar-header{text-align:center;flex:0;padding-left:0.5em;margin:0 auto}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:baseline;flex:0;margin:0 auto;column-gap:1em;border-top:1px solid #a2a9b1}}.mw-parser-output .navbox+link+.portal-bar-bordered{margin-top:-1px}.mw-parser-output .navbox+style+.portal-bar-bordered{margin-top:-1px}.mw-parser-output .portal-bar+.navbox-styles+.navbox{margin-top:-1px}</style><div class="portal-bar noprint metadata noviewer portal-bar-bordered" role="navigation" aria-label="Portals"><span class="portal-bar-header"><a href="/wiki/Wikipedia:Contents/Portals" title="Wikipedia:Contents/Portals">Portal</a>:</span><div class="portal-bar-content"><div class="portal-bar-item"><span class="portal-bar-logo"><a href="/wiki/File:WHO_Rod.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/8px-WHO_Rod.svg.png" decoding="async" width="8" height="19" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/12px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/16px-WHO_Rod.svg.png 2x" data-file-width="107" data-file-height="250" /></a></span><span class="portal-bar-link"><a href="/wiki/Portal:Medicine" title="Portal:Medicine">Medicine</a></span></div></div></div></div>